[go: up one dir, main page]

CN112585257A - System, method and device for automatic cell culture - Google Patents

System, method and device for automatic cell culture Download PDF

Info

Publication number
CN112585257A
CN112585257A CN201980054961.1A CN201980054961A CN112585257A CN 112585257 A CN112585257 A CN 112585257A CN 201980054961 A CN201980054961 A CN 201980054961A CN 112585257 A CN112585257 A CN 112585257A
Authority
CN
China
Prior art keywords
cell culture
module
cell
automated system
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980054961.1A
Other languages
Chinese (zh)
Inventor
伊曼纽尔·拿撒勒
埃里克·杰维斯
马丁·奥基恩
卡里克·法里斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Stem Cell Technology Co
Original Assignee
Canadian Stem Cell Technology Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Stem Cell Technology Co filed Critical Canadian Stem Cell Technology Co
Publication of CN112585257A publication Critical patent/CN112585257A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48Automatic or computerized control
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/20Material Coatings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/48Holding appliances; Racks; Supports
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/04Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by injection or suction, e.g. using pipettes, syringes, needles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/30Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
    • C12M41/36Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of biomass, e.g. colony counters or by turbidity measurements
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/44Means for regulation, monitoring, measurement or control, e.g. flow regulation of volume or liquid level
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/46Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0696Artificially induced pluripotent stem cells, e.g. iPS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/06Investigating concentration of particle suspensions
    • G01N15/0606Investigating concentration of particle suspensions by collecting particles on a support
    • G01N15/0612Optical scan of the deposits
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1429Signal processing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1429Signal processing
    • G01N15/1433Signal processing using image recognition
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1006Investigating individual particles for cytology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1486Counting the particles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Clinical Laboratory Science (AREA)
  • Computer Hardware Design (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Signal Processing (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了用于细胞的自动化培养的系统和方法,以及用于解离一种细胞培养物中的一个或多个集落的装置和方法。所述自动化系统至少包括一个成像模块、一个移液器模块、一个处理模块以及可选的一个载物台模块。通过至少一个处理器实现前述模块的协调操作,该协调操作是基于从在一个第一时间点和一个或多个后续时间点采集的一张或多张图像计算出的所述细胞培养物的一个或多个特征。所述装置包括一个安装表面,其具有一个或多个冲击缓冲器,其被连接至一个可旋转驱动器;一个平台,该平台可依赖于或不依赖于所述驱动器而旋转;以及一个或多个冲击托架,该冲击托架连接至所述平台并可与所述一个或多个冲击缓冲器碰撞,以将解离力传递到所述平台上的一个细胞培养容器中的一种细胞培养物上。

Figure 201980054961

The present invention discloses systems and methods for automated culturing of cells, as well as devices and methods for dissociating one or more colonies in a cell culture. The automated system includes at least an imaging module, a pipette module, a processing module, and optionally a stage module. Coordinated operation of the aforementioned modules is effected by at least one processor, the coordinated operation being based on one of the cell cultures calculated from one or more images acquired at a first time point and one or more subsequent time points or multiple features. The device includes a mounting surface having one or more shock bumpers connected to a rotatable drive; a platform that can rotate with or without the drive; and one or more an impact bracket connected to the platform and collided with the one or more impact bumpers to transmit dissociative forces to a cell culture in a cell culture vessel on the platform superior.

Figure 201980054961

Description

System, method and device for automatic cell culture
Cross Reference to Related Applications
This application claims priority to U.S. provisional patent application No. 62/686,962 filed on 2018, 6/19, the entire contents of which are incorporated herein by reference.
Technical Field
The present application relates to the culture of cells, and in particular to the automated culture of cells.
Background
Maintaining a cell culture may involve, among other things, frequent replacement of the culture medium, monitoring of cell density, passage or subculture for downstream applications, such as maintenance or expansion, and harvesting of the cultured cells for downstream applications.
Depending on the scale of cell culture in a laboratory, routine maintenance of cells may place an undue time burden on the researcher or technician. Furthermore, inconsistencies in the actual operation of cell cultures, either by individual investigators or technicians themselves, or between team members, can result in suboptimal cellular characteristics, such as, but not limited to, survival, growth rate, phenotype, metabolism, and the like. In addition, conventional cell culture may lead to repetitive strain injury by the relevant researcher or technician.
In the case where the scale of cell culture in a laboratory is not necessarily large, the downstream application of the cultured cells may also determine the actual method of operation of certain cell cultures. For example, if the cultured cells are to be used in clinical applications, a degree of compliance may be required to minimize human exposure to the cell culture. Alternatively, the regulations or guidelines may require spatially and temporally consistent culturing/subculturing of cell cultures.
In fact, automated culture of cells may solve some of the problems described above, while also providing other potential benefits.
One aspect of an automated approach to cell (including but not limited to stem cell) culture has not been solved by the prior art, i.e., involving consistent culture/subculture from passage to passage. A different or related challenge for culturing/subculturing cells may be caused by different wells of one cell culture container or different growth dynamics of the cells in different cell culture containers. These and other challenges are exacerbated when culturing sensitive cell types (e.g., primary cells or stem cells). Specific examples of the sensitive stem cells may include Mesenchymal Stem Cells (MSC), epithelial stem cells, neural stem cells, Embryonic Stem Cells (ESC), and Induced Pluripotent Stem Cells (iPSC). Embryonic Stem Cells (ESCs) and Induced Pluripotent Stem Cells (IPSCs) may be broadly referred to as Pluripotent Stem Cells (PSCs), among other pluripotent cell types.
Pluripotent Stem Cells (PSCs) tend to grow as dense, adherent colonies or aggregates of up to thousands of cells. Based on certain visual, morphological, or phenotypic cues, a researcher or technician will wish to subculture cells of a Pluripotent Stem Cell (PSC) culture. Indeed, Pluripotent Stem Cells (PSC) of mice can be subcultured after complete dissociation into individual Pluripotent Stem Cells (PSC) or clusters with little or no effect on the formation of new colonies in subsequent cultures. In contrast, human Pluripotent Stem Cells (PSCs) tend to perform poorly in subsequent cultures when completely dissociated into individual Pluripotent Stem Cells (PSCs) due to, for example, karyotypic instability. However, it often performs better when human Pluripotent Stem Cells (PSCs) are dissociated into small (about 5 or more) clusters prior to subculture.
It is well known that culture conditions (e.g., passage time) can affect the properties of a cell culture and thus its utility in downstream applications. The above situation underscores the importance of consistent cell culture practices in order to have confidence in the reproducibility of results for downstream applications. It is therefore important that passaging of the cell culture is performed at an optimal time point, rather than at the most convenient time point for the researcher or technician. In view of the complexity of culturing/subculturing cells, including but not limited to stem cells such as Pluripotent Stem Cells (PSC), several of which have been described previously, there is a need for an automated cell culture system that can adaptively culture and passage cells in order to obtain consistent progeny cultures during subsequent passages.
Disclosure of Invention
Systems and methods for culturing a cell culture are disclosed. In a specific embodiment, the cell culture may be a pluripotent stem cell, and optionally may be a human pluripotent stem cell. In a more specific embodiment, the cell culture (e.g., human pluripotent stem cells) may be cultured as an (adherent) cell culture. The invention also describes systems and methods for passaging or expanding a cell culture, such as pluripotent stem cells. In some embodiments, the systems and methods are automated.
In one broad aspect, the present invention describes an automated system for adaptive passaging of a cell culture in a cell culture medium within a cell culture vessel. The automated system comprises an imaging module for acquiring one or more images of the cell culture at a first point in time and one or more subsequent points in time, a pipette module having one or more pipettes for drawing liquid from the cell culture vessel via a pipette tip that mates with a tip of the one or more pipettes, a liquid dispenser module spaced apart from the pipette module in fluid communication with more than one reservoir, a processing module having a pair of opposing arms for gripping and transporting cell culture containers or their lids or progeny cell culture containers or their lids within the automated system, and at least one processor in communication with the imaging module, pipette module, liquid dispenser module, and processing module. The processor is configured to receive one or more images from the imaging module, calculate one or more characteristics of the cell culture based on the one or more images received from the imaging module, and execute an automated passaging experiment plan to passage the cell culture, the experiment plan including a coordination of operations of the pipette module, liquid dispenser module, and imaging module based on comparing the calculated one or more characteristics of the cell culture to a known threshold level or an input threshold level of the one or more characteristics.
In some embodiments, the one or more features include: a measure of the degree of fusion of the cell culture; a measure of the morphology of the cells or colonies of the cell culture; a measure of differentiation of cells or colonies of the cell culture; a measure of colony size distribution of the cell culture; a) a measure of change from the first point in time to the one or more subsequent points in time; or a) a measure relative to b), c) or d), b) a measure relative to a), c) or d), c) a measure relative to a), b) or d), or d) a measure relative to a), b) or c).
In some embodiments, the known or input threshold level is: for a), the degree of cell or colony fusion is between about 30-90%; for b), approximately between ± 30% of a control culture; for c), approximately 0-30% of the control culture in the maintenance protocol or 50% -100% of the control culture in the differentiation protocol; or for d) is within about 15% of an average colony size distribution of a control culture or a sub-fraction thereof.
In some embodiments, at the first time point or one or more subsequent time points, the one or more characteristics calculated for the cell culture in the cell culture vessel are different from the second cell culture in a second cell culture vessel and become more consistent during a subsequent passage.
In some embodiments, the imaging module comprises a camera capable of resolving individual cells in the culture vessel.
In some embodiments, the system further comprises a stage module for supporting the cell culture container.
In some embodiments, the stage module is movable in a first plane along a first axis or a second axis or both.
In some embodiments, the stage module or a subcomponent thereof pivots about an edge thereof along a third axis.
In some embodiments, the one or more pipettes are attached to a carriage.
In some embodiments, the liquid distributor module comprises more than one conduit, and each conduit is in fluid communication with a separate one of the more than one reservoirs.
In some embodiments, the liquid dispenser module comprises a first conduit (in fluid communication with a reservoir of a first solution) and a second conduit (in fluid communication with a reservoir of a second solution), and the first solution and the second solution are simultaneously dispensed into a progeny cell culture container.
In some embodiments, each catheter is reusable or replaceable.
In some embodiments, the system further comprises a housing to house at least the imaging module, pipette module, liquid dispenser module, stage module, and processing module.
In some embodiments, the housing is sterile.
In some embodiments, the system further comprises a refrigeration module for storing one or more of the one or more reservoirs and a reservoir, wherein the one or more reservoirs, the refrigeration module, and the waste reservoir are located outside of the housing.
In some embodiments, the waste reservoir is in fluid communication with a waste chute within the housing.
In some embodiments, the waste chute is coated with a hydrophobic coating.
In some embodiments, the system further comprises one or more sensors, wherein the one or more sensors are configured to detect and report a load mass on the imaging module, on the stage module, or in the one or more reservoirs in order to detect a load mass on the imaging module, on the stage module, or in the one or more reservoirs; and trigger an alarm when the load mass is different from expected.
In some embodiments, the system further comprises an enclosed conveyor module coupled to the housing and an incubator module and configured to convey the cell culture containers from the incubator module to the vicinity of the processing module.
In some embodiments, the incubator module maintains permissive environmental conditions for the cell culture.
In some embodiments, the system further comprises a graphical user interface.
In some embodiments, the graphical user interface displays one fluid level report for each of the one or more reservoirs.
In another broad aspect, the invention describes an automated system for adaptive subculturing of a pluripotent stem (adherent) cell culture in a cell culture medium within a cell culture vessel. The automated system comprises an imaging module for acquiring one or more images of the pluripotent stem cell culture at a first point in time and one or more subsequent points in time; a pipette module having one or more pipettes for aspirating liquid from the cell culture vessel through a pipette tip mated with a tip of the one or more pipettes; a liquid dispenser module spaced apart from the pipette module and in fluid communication with one or more reservoirs; a processing module having a pair of opposing arms for holding and transporting the cell culture container or lid thereof or a progeny cell culture container or lid thereof within the automated system; and at least one processor in communication with the imaging module, the pipette module, the liquid dispenser module, and the processing module. The processor is configured to: receiving one or more images from the imaging module; calculating one or more characteristics of the cell culture based on the one or more images received from the imaging module, and executing an automated passaging experimental plan to passage the cell culture, the experimental plan including a coordination of operation of the pipette module, liquid dispenser module, and imaging module based on comparing the calculated one or more characteristics of the cell culture to a known threshold level or an input threshold level of the one or more characteristics.
In another aspect, the invention describes an automated method for adaptively passaging a cell culture. The method comprises the following steps: providing said cell culture in a cell culture medium in a cell culture vessel; acquiring one or more images of the cell culture at a first time point and one or more subsequent time points by an imaging module; calculating, by at least one processor communicatively coupled to the imaging module, one or more characteristics of the cell culture based on the one or more images; and executing, by the at least one processor, an automated passaging experiment plan based on comparing the calculated one or more characteristics of the cell culture to a known threshold level or a predetermined threshold level of the one or more characteristics.
In some embodiments, providing the cell culture comprises transferring the cell culture from the incubator.
In some embodiments, the method further comprises placing the cell culture container on a stage module.
In some embodiments, the method further comprises obtaining a cell suspension from the cell culture and seeding a progeny cell culture vessel with a portion or all of the cell suspension.
In some embodiments, prior to seeding into the progeny cell culture vessel, the cell suspension is transferred through a first pipette tip, thereby dissociating the cell culture into a single cell suspension or clusters (whose average diameter does not exceed the pore diameter of the first pipette tip).
In some embodiments, obtaining the cell suspension comprises aspirating the cell culture medium from the cell culture vessel and contacting the cell culture in the cell culture vessel with a separation liquid.
In some embodiments, the separation solution is a dissociation solution, and the dissociation solution selectively exfoliates a first set of differentiated cells or a second set of undifferentiated cells from the walls of the cell culture vessel.
In some embodiments, the method further comprises simultaneously dispensing a first solution and a second solution into the daughter cell culture vessel prior to seeding the cell suspension.
In some embodiments, the first solution is the cell culture medium and the second solution is a solubilized extracellular matrix.
In some embodiments, the cell culture is a pluripotent stem cell.
In some embodiments, the pluripotent stem cell is a human pluripotent stem cell.
In some embodiments, the pluripotent stem cells are passaged in clusters.
In another aspect, the invention describes an automated method for adaptively passaging a pluripotent (adherent) cell culture. The method comprises the following steps: providing said cell culture in a cell culture medium in a cell culture vessel; acquiring one or more images of the cell culture at a first time point and one or more subsequent time points by an imaging module; calculating, by at least one processor communicatively coupled to the imaging module, one or more characteristics of the cell culture based on the one or more images; and said at least one processor executing an automated passaging experiment plan based on comparing said calculated one or more characteristics of said cell culture to a known threshold level or a predetermined threshold level of said one or more characteristics.
In some embodiments, the method further comprises aspirating said cell culture medium from said cell culture vessel and contacting said pluripotent stem (adherent) cell culture in said cell culture vessel with a separation fluid to produce a cell suspension.
In some embodiments, the separation solution is a dissociation solution that produces the cell suspension (as a first set of differentiated cells or a second set of undifferentiated cells that selectively dissociate) from the cell culture vessel walls.
In some embodiments, the cell suspension comprises clusters of pluripotent stem cells (the average diameter of which does not exceed the pore size of a first pipette tip through which the cell suspension can pass).
In some embodiments, the method further comprises seeding the cell suspension into a progeny culture vessel.
In some embodiments, the method further comprises simultaneously dispensing a first solution and a second solution into the progeny culture container prior to seeding the cell suspension.
In some embodiments, the first solution is the cell culture medium and the second solution is a solubilized extracellular matrix.
In another broad aspect, methods are provided for isolating one or more colonies in a cell culture. The method comprises the following steps: providing an apparatus according to the invention; placing a cell culture vessel containing one or more colonies of said cultured cells that have been exposed to a separation fluid on a platform of said device; rotating the platform under the influence of a drive; and repeatedly colliding one or more impact brackets of the device with one or more impact bumpers of the device, the one or more impact brackets coupled to the platform to transmit a force to the platform and the cell culture vessel thereon to dissociate the one or more colonies in the cell culture.
In some embodiments, the method further comprises immobilizing the cell culture on the platform.
In some embodiments, the platform may be rotated in a clockwise direction. In some embodiments, the platform may be rotated in a counter-clockwise direction.
In some embodiments, the method may further comprise regularly alternating rotation of the driver between a clockwise direction and a counter-clockwise direction. In particular embodiments, the rule transformation may include a delay of less than 5 seconds between clockwise and counterclockwise rotation. In a more specific embodiment, the rule transformation may include a delay of less than 1 second between clockwise and counterclockwise rotation. In a more specific embodiment, the rule transformation may include a delay of about 0.5 milliseconds or less between clockwise and counterclockwise rotation.
In some embodiments, one or more colonies of cell culture may be directly or indirectly adhered to a bottom of a well of the cell culture vessel.
In some embodiments, the one or more colonies of the cell culture can be one or more undifferentiated colonies in a pluripotent stem cell culture.
In another broad aspect, an automated system for passaging pluripotent stem cells is provided. The system comprises: a stage module for supporting one or more cell culture vessels; a cell culture container processing module; a pipette module; a liquid dispenser module spaced from the pipette module, the liquid dispenser module in fluid communication with a plurality of reservoirs; a dissociation module of the apparatus according to any one of claims 1-14; a waste reservoir; and a controller for coordinating the operation of each of said modules of said automation system.
In some embodiments, the stage module may include a platform, and the platform or a sub-component thereof is movable. In some embodiments, the platform or a subcomponent thereof may be movable in a first plane. In some embodiments, the platform or a subcomponent thereof is movable in a path along a first axis and a second axis. In some embodiments, the platform or a subcomponent thereof may also move in a path along a third axis.
In some embodiments, the processing module may include a pair of opposing arms.
In some embodiments, the pipette module may include more than one pipette, and the tip of each pipette may mate with one disposable pipette tip.
In some embodiments, the pipette module and the processing module are both comprised in one mobile unit.
In some embodiments, the liquid dispensing module may include more than one line, and each line may be in fluid communication with a separate one of the more than one reservoirs. In some embodiments, each of the more than one lines is reusable. In some embodiments, each of the more than one lines is replaceable.
In some embodiments, the system further comprises an imaging module, wherein the imaging module comprises a camera capable of resolving individual cells in wells of one or more culture vessels. In some embodiments, the imaging module may include an image processor to query a characteristic of a pluripotent stem cell culture in the wells of the one or more culture vessels.
In some embodiments, the system further comprises an incubator module, wherein the incubator module maintains allowable environmental conditions for the pluripotent stem cell culture.
In some embodiments, the system further comprises a conveyor module to transport the one or more cell culture vessels from the incubator to the vicinity of the processing module.
In some embodiments, the system further comprises a refrigeration module to store one or more of the one or more reservoirs.
In some embodiments, the system further comprises a housing for housing at least the stage module, the processing module, the pipette module, and the vortex module.
In some embodiments, the one or more reservoirs, the refrigeration module, and the waste reservoir are located outside of the housing.
In some embodiments, the system further comprises a graphical user interface. In some embodiments, the graphical user interface may display a fluid level report for each of the one or more reservoirs.
In another broad aspect, a method for automated passaging of cells is provided. The method comprises the following steps: providing a system as disclosed herein; placing a first cell culture container of cells on a stage module using the processing module; aspirating media from a well of the first cell culture vessel using the pipette module; dispensing a dissociation solution into the wells of the first cell culture vessel using the liquid dispensing module; stripping a cell colony from the bottom of the well of the first cell culture vessel using the dissociation module; dissociating the detached cell colony into a cell suspension; using the pipettor module, seeding a volume of the cell suspension into a well of a second cell culture vessel.
In some embodiments, the method further comprises transporting the first cell culture container from the incubator module using the conveyor module prior to the placing step.
In some embodiments, the method further comprises tilting the first cell culture vessel using the stage module prior to the aspirating step.
In some embodiments, the method further comprises washing the wells of the first cell culture vessel with a dispensed wash buffer using the liquid dispensing module after the aspirating step.
In some embodiments, the method further comprises incubating the first cell culture vessel in the incubator module after the dispensing step.
In some embodiments, the method further comprises comminuting the exfoliated cell colonies into a cell suspension.
In some embodiments, the method further comprises placing a second cell culture container on a stage module using the processing module prior to the seeding step.
In some embodiments, the method further comprises transferring the second cell culture container to the incubator module using a conveyor module.
Other features and advantages of the present invention will become apparent from the following detailed description. However, it should be understood that the detailed description and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
Drawings
For a better understanding of the described embodiments of the invention, and to show more clearly how the various embodiments herein may be carried into effect, reference is made to the accompanying drawings which show, by way of illustration, at least one embodiment and which will now be described. The drawings are not intended to limit the scope of the technical teachings described herein.
Figure 1 shows a top view of one embodiment of an automated system for passaging a cell culture. Optional components are shown in phantom.
Fig. 2 illustrates a side view of one embodiment of one imaging module used in the automated system described herein.
Fig. 3 shows a front view (a) and a side view (B) of an embodiment of a carriage used in the automation system described herein.
Fig. 4 shows (a) representative images of a living cell culture acquired at different time points using the imaging module, and (B) the corresponding transformation pattern of the living cell image shown in a (cell areas shown in grey). The images shown are day 2, day 3, day 4, day 5, day 6 and day 7, respectively, as noted.
FIG. 5 shows that the degree of fusion of a cell culture can be determined based on the one or more images acquired by the imaging module. Visual contrast (a) of the fusion of a live cell imaged cell culture (using the uploading imaging module) with the corresponding transformation pattern of a stained cell culture (stained using Hoechst and imaged using fluorescence microscopy (Hoechst 33258, 352nm excitation, 461nm emission)). Regression analysis (B) on the% confluency was determined by live cell imaging (by using imaging module wells) on 194 cell cultures or Hoechst staining on the same 194 cells. Each dot represents a cell culture vessel(i.e., the wells of a 6-well plate). (C) A graph summarizing the% confluency of one well in each indicated cell type cultured under each indicated condition in a plurality of serial passages. Various conditions indicated include mild Cell Dissociation reagents (GCDR)TM) (Stem cell technology Co.) or ReLeSRTM(Stem cell technology Co.) (Cluster-based Generation), TeSR-E8TM(Stem cell technology Co.) or mTeSR1TM(Stem cell technology) maintenance media, iPS or ES cell lines, and various cell lines.
Fig. 6 illustrates various methods by which the% fusion can be determined at more than one time point. (A) A graph is shown in which the% confluency of 6 cell cultures (i.e., each well of a 6-well plate) is fitted to an exponential growth model. (B) A histogram is shown in which% confluence and the exponential fit can be used to calculate doubling time for 162F 016 cell cultures (mean 33.1 hours, standard deviation ± 7.2 hours). (C) A histogram is shown in which% confluence and exponential fit can be used to calculate doubling time for 186H 9 cell cultures (average 37.9 hours, standard deviation ± 14.9 hours). (D) Regression analysis (R) showing predicted day 7 and actual day 7 fusions20.95). The predicted day 7 fusibility was determined by fitting the day 2 to day 6% fusibility data to an exponential growth model as shown in (a).
Fig. 7 shows that the% confluence can be calculated from one or more images of spray passaged cells and single-cell passaged cells. (A) Representative images of each well of a 6-well plate of spray-passaged H9 cells are shown. (B) The corresponding masked area for each hole in (a) is shown. (C) The corresponding% fusion values obtained after image analysis of the masked regions in (B) are shown. (D) Representative images of each well of a 6-well plate of single cell passaged M001 cells are shown. (E) The corresponding masked area for each hole in (D) is shown. (F) The corresponding% fusion values obtained after image analysis of the masked regions in (E) are shown.
FIG. 8 shows the average colony surface of a cell culture of 24 wells (i.e., each well of a 6-well plate)A regression analysis of the product, the calculation of which is based on the average colony area of one or the images acquired by the imaging module and of the same cell culture determined by Hoechst staining (R)2=0.86,p=0.94);
FIG. 9 shows regression analysis of total intensity (in arbitrary units) in 24 cell cultures, the calculation of which is based on one or more images acquired by the imaging module and the actual number of cells (R) in the same cell culture2=0.94,p<0.0001). The total intensity is defined as the sum of the intensities of each pixel within the image mask area. To generate the actual cell count, all cells were harvested from the culture vessel and used to generate a single cell suspension, which was then sampled for counting.
Fig. 10 shows the result of applying a machine learning algorithm to a set of images acquired by the imaging module. (A) Representative images of the cell culture after cropping, taken by the imaging module, are shown. (B) A superposition of the background (darkest), differentiated (brightest) and undifferentiated (middle) automatically classified regions of the representative image shown in (a) is shown. (C) The results of three different classification models are shown. Model 3 classifies all pixels into the most common class, undifferentiated, and is listed as a control.
FIG. 11 illustrates the use of ReLeSRTM(Stem cell technology company) percentage of differentiated area remaining in cultures of 3 different cell lines after an automatic passaging experimental plan. For each cell line, 6 different wells were evaluated for neural colonies, fibroblast-like colonies, fully differentiated colonies (whole) and complex differentiated colonies.
FIG. 12 shows a graph in which the calculation of% confluency for a cell culture at more than one earlier time point can be used to predict the time at which the cell culture will reach the desired% confluency (with higher time resolution). Each line corresponds to a different cell culture vessel (i.e., the wells of a 6-well plate);
fig. 13 shows a dot plot of the coefficient of variation in the 6 wells of a 6-well plate at day 7% confluence for 3 serial passages of 1C cells. Adaptive passaging based on the calculated% confluency may result in a more consistent% confluency in the cell culture at a subsequent time point. No significant difference in the coefficient of variation between P0 and P2 was observed based on the Wicoxon signed rank test of paired samples compared to that between P1 and P2. At P0, all wells of a given plate were seeded with the same volume. At P1, use was made of from 1:25 to 1: dilutions of 200 were passaged through wells to obtain increased Covariance (COV). At P2, a regression model was used for the adaptive passage, and the split ratio was selected for each well so that the wells would revert to having similar confluency.
Fig. 14 shows a perspective view (a) and a cross-sectional perspective view (B) of an embodiment of a chute used in the automated system of the invention;
FIG. 15 shows a flow diagram of an embodiment of a method for passaging a cell culture;
figure 16 shows a perspective view of the device for dissociating one or more colonies present in a cell culture;
figure 17 shows a front view of the device for dissociating one or more colonies present in a cell culture;
figure 18 shows a side view of the device for dissociating one or more colonies present in a cell culture;
figure 19 shows a top view of the device for dissociating one or more colonies present in a cell culture. For illustrative purposes, the stage is not shown, but the impact cradle is shown generally attached thereto.
Detailed Description
Various systems, devices, and methods are described below to provide one example of at least one implementation of claimed subject matter. Any embodiments described below do not limit any claimed subject matter, and any claimed subject matter may encompass systems, apparatuses, and methods that differ from those below. The claimed subject matter is not limited to systems, apparatuses, and methods having all of the features of any one of the systems, apparatuses, or methods described below, nor to systems, apparatuses, and methods having common features of many or all of the systems, apparatuses, and methods described below. The claimed subject matter may reside in any combination or subcombination of the components or process steps disclosed in any portion herein (including the claims and drawings thereof). Thus, those skilled in the art will appreciate that a system, apparatus, or method disclosed herein, in conjunction with the teachings herein, may embody any one or more of the features included herein, and that such features may be used in any specific combination or sub-combination (combinations or sub-combinations that are physically possible and that achieve their intended purpose).
Further, the systems, devices, or methods described below may not be implementations of any claimed subject matter. Any subject matter disclosed in, but not claimed herein, of the systems, apparatus, or methods described herein can be subject matter of another protective document, e.g., a continuous patent application, and applicant, inventor, and/or owner does not intend to disclaim, or claim or contribute to the public by disclosing it herein.
It will also be appreciated that where considered appropriate, reference numerals have been repeated among the figures to indicate the same or similar elements for purposes of simplicity and clarity of illustration. In addition, numerous specific details are set forth in order to provide a thorough understanding of the exemplary embodiments described herein. However, it will be understood by those skilled in the art that the exemplary embodiments described herein may be practiced without these specific details. In other instances, well-known methods, procedures, and components have not been described in detail so as not to obscure the example embodiments described herein. Furthermore, this description is not to be taken as limiting the scope of the exemplary embodiments described herein.
It is noted that terms of degree such as "substantially", "about" and "approximately" as used herein mean a reasonable amount of deviation of the modified term such that the result is not significantly changed. These terms of degree should be construed as including a deviation of the modified term such as 1%, 2%, 5% or 10% if this deviation would not negate the meaning of the term it modifies.
Moreover, any numerical range given by endpoints herein is intended to include all numbers and fractional decimal values within that range (e.g., 1 to 5 includes 1, 1.4, 2, 2.72, 3, 3.90, 4, and 5). It is also to be understood that all numbers and fractional decimal points are assumed to be modified by the term "about," which means a certain number of changes up to the number referred to, for example, 1%, 2%, 5%, or 10%, if the end result is not significantly changed.
It should also be noted that, as used herein, the term "and/or" is intended to mean an inclusive "or". That is, "X and/or Y" is intended to mean either X or Y or both. As another example, "X, Y, and/or Z" is intended to mean X or Y or Z or any combination thereof.
The present invention describes systems, devices and methods for culturing or dissociating one or more colonies in a cell culture. In a specific embodiment, the cell culture is a pluripotent stem cell, and optionally a human pluripotent stem cell. In a more specific embodiment, the cell culture (e.g., human pluripotent stem cells) comprises a mass or cluster of human pluripotent stem cells dissociated from one or more colonies. The invention also describes the integration of the device and/or method into a system and method for passaging or expanding a cell culture. In a particular embodiment, the system and method are automated.
As used herein, "passaging" refers to the activities of cell culture up to a point in time at which a cell culture can be passaged or sub-cultured, as well as activities associated with passaging or sub-culturing a cell culture, including seeding some or all of the cell culture in fresh medium into one or more daughter cell culture vessels. Thus, the term "passaging" is intended to include activities associated with the routine culturing of cells, such as subculture of said cell culture, as well as work-flows directed to expanding, harvesting (e.g. cryopreservation) or differentiating a cell culture or to loading a newly derived cell line. In one embodiment, a volume of a cell suspension from a first cell culture vessel can be seeded in only one progeny cell culture vessel (i.e., 1:1 passage). In one embodiment, a volume of a cell suspension from a first cell culture vessel can be seeded into a plurality of daughter cell culture vessels (i.e., 1: n +1 passages, which can be considered as an expanded form).
As used herein, "cell culture" refers to any type of cell that can be cultured, passaged, expanded, or differentiated in one cell culture vessel. In one embodiment, the cell is an anchored, independent cell, such as a hematopoietic stem cell or progenitor cell thereof. In one embodiment, the cells are anchorage-dependent cells, such as those cultured in a monolayer or a (adherent) cell culture. In one embodiment, the anchorage-dependent cell is a mesenchymal stem cell. In one embodiment, the anchorage-dependent cell is a Pluripotent Stem Cell (PSC). The Pluripotent Stem Cells (PSC) can be embryonic stem cells, naive stem cells, expanded pluripotent stem cells, or induced pluripotent stem cells.
As used herein, "cell culture vessel" or "progeny cell culture vessel" refers to a vessel that can be used to support cell culture. A cell culture container may be a single flask or dish, such as a circular dish, or may be a multi-well culture plate. When the cell culture vessel corresponds to a multi-well culture plate, each well, some wells, or all wells thereof may be considered a cell culture vessel. In particular, after the passaging process is carried out and once the cell culture is inoculated into new cell culture vessels, the new cell culture vessels are referred to herein as progeny cell culture vessels.
System for controlling a power supply
In one aspect of the invention, a system for passaging a cell culture is described. In one embodiment, the cell is a Pluripotent Stem Cell (PSC), even more specifically, the cell can be a human Pluripotent Stem Cell (PSC). In one embodiment, Pluripotent Stem Cells (PSCs), whether human or otherwise, may be cultured or passaged as a (adherent) cell culture. Since it is desirable in many applications to passage cells, such as human Pluripotent Stem Cells (PSC), as a clump or cluster, the automated systems and methods for passaging such cells may be adapted to the clump passage thereof.
In one embodiment, an automated system 1 for passaging a cell culture (e.g., human pluripotent stem cells) includes various modules including: an imaging module 100, a pipette module 200, a liquid dispenser module 300, more than one reservoir 350 (e.g., 350a, 350b, 350c, etc.), a processing module 400, optionally a stage module 500, and a processor 600 (for coordinating operation of the modules of the automated system) (see fig. 1 and 3).
The imaging module 100 includes a camera 105. in one embodiment, the camera 105 may be placed above a stage 110 (FIG. 2). In one embodiment, the camera 105 may be fixed above or movable above the stage 110. In one embodiment, the camera 105 may be movable fixed under or under the stage 110. When a cell culture container is placed on stage 110, camera 105 may acquire one or more images of the cell culture in the cell culture container at a first point in time and at one or more subsequent points in time with appropriate dimensions and resolution.
In one embodiment, the lens (not shown) of the camera 105 is directed substantially horizontally with respect to the plane of the stage 110, and one or more images of the cell culture are acquired by means of a mirror 120 (see fig. 2). Mirror 120 is placed at a suitable distance from the lens of camera 105 and at an angle sufficient to reflect an object plane (i.e., the cell culture within the cell culture vessel) to a focal plane of camera 105. In one embodiment, the angle 125 of the mirror 120 is about 45 °.
Camera 105 is associated with sufficient computer readable memory to store one or more images of thousands of cell culture vessels, possibly taken at tens of time points. The computer-readable memory may be localized to the camera 105 and/or may be stored remotely, such as on a personal computer device or on the cloud (i.e., on a remote server).
In one embodiment, the camera 105 captures moving or still images. In one embodiment, the camera 105 captures a black and white (or grayscale) or color still image. In one embodiment, one or more images are acquired using dark field techniques, wherein the field of view around the cell culture is generally dark and the cell culture provides sample contrast.
In one embodiment, camera 105 is capable of imaging an area of a cell culture vessel used to culture cells. In such embodiments, the cell culture vessel may be a 35mm dish or a 100mm dish. Also in such embodiments, the cell culture vessel may be a 6-well plate, and the camera 105 may acquire a single image of the cell culture area including each of its 6 wells. Such images may be stored as such, or, for example, may be stored with 6 related files as a subset of the cropped image corresponding to each hole thereof. In one embodiment, 6 separate images corresponding to each well of a 6-well plate may be acquired. The skilled artisan will appreciate that the cell culture vessel may be in any form, such as, but not limited to, a 12-well, 24-well, 96-well, or 384-well plate, and that in any event camera 105 may capture one or more images including each well (or desired subset) thereof or individual images of each well (or desired subset) thereof.
In certain embodiments, the camera 105 is capable of resolving individual cells in the cell culture vessel or well thereof. In such embodiments, or in different embodiments, camera 105 is capable of resolving individual colonies of one cell culture in the cell culture vessel or well thereof. Since the camera 105 is capable of acquiring one image of the entire cell culture vessel (or its wells), the camera 105 is also capable of resolving each of the individual cells or colonies of a cell culture within one cell culture vessel.
In some embodiments, imaging module 100 includes an image processor to query one or more characteristics of a cell culture (e.g., Pluripotent Stem Cells (PSCs)) in the cell culture vessel. By querying the one or more characteristics, the system 1 may perform an appropriate operation, such as a medium change experiment plan, a passaging experiment plan, an expansion experiment plan, a differentiation experiment plan, or a culture termination experiment plan. In other embodiments, the processor for querying one or more features is not included within the imaging module 100, but may be included separately, for example, within a centralized processor module (which may be included within a computer device). Accordingly, the system 1 may include at least one processor (described in detail below).
In one embodiment, object table 110 includes one or more load cells to detect and report the presence and weight of a cell culture container thereon. Thus, the one or more load cells may provide feedback to the system 1 as to whether to start operation. For example, if the stage 110 does not have a cell culture container present, this may mean that the imaging operation cannot be performed. In one embodiment, one or more load cells verify that an appropriate volume of solution has been added or removed from a cell culture vessel. In one embodiment, the sensitivity of the one or more load cells is sufficient to verify that the lid has been removed from a cell culture container.
In one embodiment, the stage 110 is separate from the stage module 500. In one embodiment, the stage 110 is a subcomponent of the stage module 500. In one embodiment, the stage 110 and the stage module 500 are the same item.
The system 1 further comprises a pipette module 200. Pipette module 200 includes one or more pipettes for drawing fluid, such as a cell culture medium, from the cell culture vessel via a pipette tip mated with the end of the one or more pipettes. The pipette module 200 also includes, in fluid communication with each of the one or more pipettes, a device that generates the necessary suction to draw liquid from the cell culture vessel.
In one embodiment, one or more pipettes of pipette module 200 may be lowered or raised to bring a pipette tip attached thereto into or out of contact with fluid in a cell culture vessel. In one embodiment, the cell culture vessel may be raised or lowered to bring fluid therein into or out of contact with a pipette tip of the one or more pipettors.
It may also be desirable for pipette module 200 and its one or more pipettes to move in system 1 relative to stage 110 along the x-axis or the y-axis, or both, regardless of whether the one or more pipettes may be raised or lowered in the vertical plane. In such embodiments, a pipette module 200 may be included in a movable unit 220 (or carriage), for example, by attaching the pipette module 200 to the movable unit 220 (or carriage) (fig. 3). In one embodiment, the carriage 220 may move along a track within the system 1 that may be suspended above the platform 227 of the system 1 or rooted to the platform 227 of the system 1. In one embodiment, the carriage 220 may extend along the length of, or substantially along the length of, one or both sides of the platform. Such carriages are known in the art, and exemplary carriages include NimbusTM(Hamilton corporation) system.
In one embodiment, the pipette tip is disposable, and thus the one or more pipettes may also include a pipette detachment mechanism. An example of a pipette disengagement mechanism includes a collar that slides over a tubular body of the one or more pipettes and disengages the pipette tip from the tubular body when an edge of the collar contacts the pipette tip.
Illustrative examples of use of pipette module 200 may include, but are not limited to: pulverizing a cell suspension; withdrawing liquid as waste from a cell culture vessel; or transferring some or all of the liquid of a cell culture vessel to a progeny cell culture vessel, such as when cells are seeded into a progeny cell culture vessel during an automated passaging protocol.
The system 1 may also include staging areas for multiple pipette tips of the pipette head. The system 1 may accommodate more than one tip rack in use and may accommodate more than one spare tip rack. In one embodiment, pipette tip rack 225 may correspond to one pipette tip rack in use, while pipette tip racks 230a, 230b, 230c, and 230d may correspond to spare pipette tip racks. Once a pipette tip in pipette tip rack 225 is depleted, a spare tip rack (230a, 230b, 230c or 230d) may be used in place of the depleted tip rack. When all pipette tips in the system 1 are used up, a user of the system 1 may load a new pipette tip rack in the staging area. The staging area (the cassette in series with pipette tip rack 225) may also be used to store cell culture containers or their lids that are accessible but not currently in close proximity to stage 110 or stage module 500.
In order to minimize the possibility of unnecessarily contaminating the system 1 or any of its components, the area where the pipette tips of the system 1 are detached from the end of one or more pipettes is an important consideration. In particular, this area should be remote from any component of the system 1 (if this component is in contact with a cell culture vessel, the pipette tip rack placement area, and the tip rack in use). In one embodiment, a pipette tip is disengaged from the one or more pipettes into a waste receptacle 250. In one embodiment, waste container 250 may be included in a slidable drawer to facilitate removal of its contents from system 1, while also minimizing user contact with system 1 components (e.g., imaging module 100, pipette module 200, pipette tips 225 and 230, and other modules described below). In one embodiment, for example, a sensor detects and reports the placement of the waste container 250, e.g., to avoid obstructing the movement of the carriage 220.
The system 1 further comprises a liquid dispensing module 300. Liquid dispensing module 300 may be spaced apart from pipette module 200. For clarity, spaced apart indicates that these are different components of the system 1, and may be at different locations of the system 1. The liquid dispensing module 300 is used for batch dispensing of a solution into a cell culture vessel, while the pipette module 200 is used for aspirating some or all of the liquid from a cell culture vessel. An illustrative example of the use of the liquid dispensing module 300 may include: dispensing a cell culture or differentiation medium into a cell culture vessel or a progeny cell culture vessel either before or after inoculation with a cell suspension; dispensing a wash buffer or cell separation fluid into a cell culture vessel during an automated passaging experiment plan of a cell culture within a cell culture vessel; or dispensing a cell culture matrix solution (e.g., a lysed extracellular matrix).
The liquid dispensing module 300 includes one or more conduits 325 (in fluid communication with one or more reservoirs 350) (see, e.g., fig. 1). The reservoir 350 contains various solutions for performing automated culturing or passaging of cells, such as pluripotent stem cells. Examples of solutions contained in the reservoir 350 include, but are not limited to: a cell culture medium, a cell differentiation medium, a cell culture matrix solution (e.g., lysed extracellular matrix), a cell wash buffer, and a cell separation solution or a cell dissociation solution.
The contents of the reservoir 350 may depend on the workflow employed by the user of the system 1 and may be replaced as desired by the user. Non-limiting examples of workflows may include: seeding cells, passaging cells, expanding cells, uploading cells, deriving clonal populations of cells, or differentiating cells. Such workflows are particularly common to users who are concerned with the automation of pluripotent stem cell cultures.
The reservoir 350 may contain any reasonable volume of solution used in a workflow employed by a user of the system 1. For example, the reservoir 350 may correspond to a 500mL bottle commonly used to hold cell culture fluid. Alternatively, the reservoir 350 may correspond to a larger bottle or bag, such as a one gallon or 10 liter jar. In some embodiments, the reservoir 350 can contain different volumes of solution. For example, a relatively larger reservoir may provide a larger volume of solution, while a relatively smaller reservoir may provide a smaller volume of solution.
As described above, the reservoir 350 is in fluid communication with one or more conduits 325 of the liquid dispensing module 300. The one or more conduits may take any form so long as a solution can be transported therethrough. In one embodiment, each of the one or more conduits corresponds to a flexible tube. The reservoir 350 and the one or more conduits may be associated with a pump for delivering the solution through each of the one or more conduits. In one embodiment, the pump is a peristaltic pump. In one embodiment, the pump may operate similar to a drain pump that draws solution from a reservoir through a conduit.
The fluid dispensing module 300 may include more than one conduit, and each conduit may be in fluid communication with a separate one of the more than one reservoirs 350, e.g., the first conduit 325a is in fluid communication with the first reservoir 350a, etc. (not shown). In embodiments where the liquid dispensing module 300 includes more than one conduit and each conduit is in fluid communication with a separate one of the more than one reservoirs 350, each conduit may be reusable and/or replaceable.
In one embodiment, liquid dispensing module 300 may include a first conduit (in fluid communication with a reservoir of a first solution) and a second conduit (in fluid communication with a reservoir of a second solution), and the first solution and the second solution are dispensed at different times. For example, the first solution may be a wash buffer and the second solution may be a cell separation or cell dissociation solution. Accordingly, an appropriate volume of the first solution may be dispensed into a cell culture vessel (which may or may not include a cell culture), and after removal of the first solution (e.g., by using pipette module 200), an appropriate volume of the second solution may be dispensed into the cell culture vessel. Alternatively, the first solution may correspond to the cell separation solution or cell dissociation solution, and the second solution may correspond to a cell culture medium. Alternatively, the first solution may correspond to a cell culture substrate and the second solution may correspond to a cell culture medium.
In one embodiment, liquid dispensing module 300 may include a first conduit (in fluid communication with a reservoir of a first solution) and a second conduit (in fluid communication with a reservoir of a second solution), and the first solution and the second solution are dispensed simultaneously. For example, the first solution may be a cell culture matrix solution and the second solution may be a cell culture medium. Thus, an appropriate volume of the first solution may be dispensed into one cell culture vessel (which may or may not include cell culture), and an appropriate volume of the second solution may also be dispensed into the cell culture vessel without removing the first solution.
The system 1 also includes a cell culture container processing module 400 (see fig. 3). The processing module 400 may include a pair of opposing arms for grasping and transporting a cell culture container or its lid, or a progeny cell culture container or its lid, within the automated system 1. The processing module 400 grasping a cell culture container or its lid may transport the container or lid to another station (i.e., module) of the system 1.
The processing module 400 may also move the pipette tip rack back and forth within the system 1. In one embodiment, the processing module 400 may transport a pipette tip rack depleted of pipette tips from a use position to the waste container 250 or to a staging area for the depleted pipette tip rack. Processing module 400 may then transport the alternate pipette tip rack 230 to the use location. In an alternative embodiment, the user may move the pipette tip rack back and forth within the system 1.
Process module 400 may also be included in carriage 220 with pipette module 200 (fig. 3A). In one embodiment, processing module 400 is a different element of pipette module 200 than carriage 220. In one embodiment, the pipette module 200 may also perform the functions of the processing module 400. For example, a pair of paddles may be engaged with the ends of two pipettors (rather than pipette tips), and the pair of paddles may be used to grasp and transport cell culture vessels or their lids within the system 1. In one embodiment, both the processing module 400 and the pipette module 200 may be included as distinct elements in the carriage 220, and the pipette module 200 may also provide a grasping function (by mating the ends of both pipettes with a pair of paddles).
The system 1 may also include a stage module 500 for supporting one or more cell culture vessels thereon. The stage module 500 may be located at least partially below the liquid dispenser module 300 and may also be located at least partially below the imaging module 100 (fig. 1).
The stage module 500 may include a platform 510, wherein the stage module 500 or the platform 510, or a sub-assembly thereof, is movable. The stage module 500 or the platform 510 or subcomponents thereof may be movable in a first horizontal plane. In embodiments where the stage module 500 or platform 510 or subcomponents thereof are movable in a first horizontal plane, they may move in a path along a first axis (i.e., an x-axis) or a path along a second axis (i.e., a y-axis), or both.
Horizontal planar movement of the stage module 500 or platform 510 or a subassembly thereof can facilitate dispersion of cells contained in the cell culture vessel or one or more wells thereof, for example, while a volume of cell suspension is seeded therein. Horizontal planar movement also facilitates the dispersion of a solution dispensed in the cell culture vessel or one or more wells thereof, such as a cell culture medium, a wash buffer, a stripping or dissociation solution, or a cell culture matrix solution (e.g., a lysed extracellular matrix).
In one embodiment, the stage module 500 or platform 510 or subcomponents thereof may also move along a path in a third axis. For example, the stage module 500 or platform 510, or subcomponents thereof, may tilt or pivot vertically along the edges of the stage module 500 or platform 510, or subcomponents thereof. In one particular embodiment, the tilt occurs at the edge of a sub-component of the stage module 500 (e.g., the platform 510).
The tilting movement of the stage module 500 or platform 510, or subcomponents thereof, may help to collect any solution that may be contained in the cell culture container into one of its corners, including each of its one or more wells. Such collection of solution within a cell culture container may facilitate the crushing or aspiration operation of the pipette module 200, including drawing a volume of cell suspension from the cell culture container to inoculate the progeny cell culture container. Thus, when a cell culture container is placed on the stage module 500 or platform 510 or a subcomponent thereof, one or more pipettes of the pipette module 200 should have access to the stage module 500 or platform 510 or a subcomponent thereof.
One particular function of the processing module 400 may be to place the cell culture container on the stage module 500 (or platform 110) before the system 1 performs its various functions (e.g., acquiring one or images) and before performing the steps of the automated method of cell culture.
In one embodiment, the stage module 500 includes one or more load cells to detect and report the presence and weight of a cell culture container thereon. Thus, the one or more load cells may provide feedback to the system 1 as to whether to start operation. For example, reporting that no cell culture container is present on the stage module 500 may mean that no liquid dispensing operation should be performed to prevent unnecessary spillage and to prevent the system 1 from having to go offline. In one embodiment, the one or more load cells are sensitive enough to verify that the lid has been removed from the cell culture container. In one embodiment, one or more load cells are sensitive enough to verify that a liquid transfer (as low as about 100pL) has occurred.
In one implementation, the stage 110 is contained in a stage module 500. In one embodiment, the stage 110 is distinct from the stage module 500.
The system 1 also includes at least one processor 600 communicatively coupled to at least the imaging module 100, the pipette module 200, the liquid dispenser module 300, and the processing module 400. In one embodiment, at least one processor 600 is communicatively coupled to at least imaging module 100, pipette module 200, liquid dispenser module 300, processing module 400, and stage module 500.
For imaging module 100, at least one processor 600 may initiate whether the command is to: placing the cell culture container on the stage 110 (or stage module 500 or platform 510 or a sub-component thereof) or removing the cell culture container from the stage 110 (or stage module 500 or platform 510 or a sub-component thereof); acquiring one or more images; or computing one or more features based on one or more images.
For the pipette module 200, the at least one processor 600 may initiate whether the command is to: from a first position in the system 1 to a second position in the system 1; aspirating a volume, e.g., a volume of cell suspension, from a cell culture vessel; crushing (i.e., pipetting up and down) a volume in a cell culture vessel; inoculating a volume of cell suspension in a daughter cell culture vessel; disengaging a pipette tip from an end of the one or more pipettes; or to discharge the pumped volume into a waste tank (see below).
For the liquid dispensing module 300, the at least one processor 600 may initiate whether the command is to: dispensing a quantity of liquid into a cell culture vessel; or to specify what solution is to be dispensed and the volume of such solution.
For the processing module 400, the at least one processor 600 may initiate whether the command is to: from a first position in the system 1 to a second position in the system 1; moving a cell culture container or its lid from a first position of the system 1 to a second position of the system 1; removing a lid of a cell culture container; or moving a pipette tip rack. The at least one processor 600 may also initiate a command to: whether to engage the pair of paddles prior to the pair of opposing arms of the process module 400.
With respect to the stage module 500, the at least one processor 600 may initiate whether the command is to: moving the stage module 500 or the platform 510 or a subcomponent thereof in a path along the X-axis or the Y-axis or both; or tilt the stage module 500 or platform 510 or a subcomponent thereof along an edge thereof.
In one embodiment, the system 1 includes a central processor 600 for coordinating the operation of the various modules of the system 1 to perform an automated passaging, culturing, expanding or differentiating experimental plan. It should be noted that the term "passaging" as used hereinafter or anywhere herein is intended that the terms "culturing", "expanding" or "differentiating" or variants thereof may be equally applicable. In such an embodiment, the processor 600 may be included in a computer device communicatively coupled to the system 1.
In one embodiment, system 1 includes one or more processors 600 for coordinating the operation of the various modules of system 1 to perform an automated passaging, culturing, expanding, or differentiating experimental plan. In such an embodiment, the first processor may be included in a first computer device communicatively coupled to the system 1, and the second processor may be included in a second computer device, which may be integrated in a module of the system 1 (e.g., an image processor of the imaging module 100) and communicatively coupled to the first processor and the system 1.
Nonetheless, the at least one processor 600 is configured to receive the one or more images from the imaging module 100 and to calculate the one or more characteristics of the cell culture based on the one or more images received from the imaging module 100.
In one embodiment, the one or more characteristics correspond to a measure of the degree of confluency of a cell culture within a cell culture vessel. The degree of fusion of the cell culture can be calculated by: analyzing one or more images to determine the surface area of the cell culture container covered by the cell culture, or the other portions of the surface area used to make the determination, and then dividing that value by the total surface area of the cell culture container, or the other portions of the surface area used to make the determination. In one embodiment, a software script may be executed to convert each of the one or more images into an expression in which gray or grayscale pixels are assigned to the cell culture versus cell cultures from a white background. In one embodiment, the cells may be designated as white, gray, or grayscale pixels on a black background. In any event, a transformed expression can be readily analyzed by the at least one processor 600 of system 1 to determine the degree of confluency of the cell culture within the cell culture vessel.
FIG. 4A shows daily images of cell cultures within the wells of one cell culture vessel. It can be confirmed by visual inspection of the images that the degree of fusion of the cell culture increases from a first (earlier) time point compared to one or more subsequent time points, but that the degree of fusion and changes thereto are difficult to quantify efficiently and reliably. Fig. 4b shows the transformed representation of each picture in fig. 4A. Based on the converted expression, the at least one processor 600 of system 1 can readily calculate the degree of confluency of the cell culture within a cell culture vessel or between multiple cell culture vessels, whether at a single point in time or across multiple points in time.
The determination of the degree of fusion based on the expression of the switch is consistent with that determined by classical methods using DNA binding dyes (e.g. florhst staining) (fig. 5A and 5B). FIG. 5A compares the actual image and transformed expression of the same cell culture vessel, unstained or stained with Hoechst. FIG. 5B verifies the consistency of the cell culture fusibility calculated using the two methods by regression analysis (R)20.9, 0.04 for standard error, 0.95 for p). FIG. 5C provesThe degree of fusion of the cell culture over a series of time points can be calculated based on one or more images of various cell lines cultured under different conditions.
In addition, based on the determination of the degree of fusion at different time points based on the expression of the transitions, it was demonstrated that the increase in degree of fusion for a cell culture approximately fits an exponential cell growth model (FIG. 6A), consistent with the expected growth rate of cells in culture. Determination of the change in degree of fusion can also be used to calculate the growth rate (i.e.doubling time) of a cell culture. Fig. 6B and C show that the calculated doubling times are consistent with the expected values for two different cell cultures (i.e. cell lines). Based on an exponential growth model determined as the change in cell culture confluence over time, it was possible to predict the confluence of cell cultures at a subsequent time point (FIG. 6D). Figure 6D demonstrates that the predicted degree of fusion at the subsequent time point is consistent with the actual degree of fusion of the same cell culture at the same subsequent time point.
Although the foregoing demonstrates that based on one or more images of a cell culture at mass passage, it is possible to calculate the degree of fusion, it is also possible to calculate the degree of fusion of a cell culture that has undergone spray passage (cells stripped by repeated washing of the cell culture medium on the cell culture, rather than mechanical scraping) or passage as a single cell (FIGS. 7A-F). Thus, the automated systems and methods disclosed herein may be applicable to cells that do not necessarily require mass passage/culture, such as mammalian cells in general, including but not limited to certain Pluripotent Stem Cell (PSC) lines, mesenchymal stem cells, epithelial stem cells, neural stem cells, cancer cell lines, and the like. In embodiments where Pluripotent Stem Cells (PSCs) are passaged as single cells, it may be necessary to include in the culture medium a supplement, such as CloneR, that promotes survival of the single Pluripotent Stem Cells (PSCs)TM(Stem cell technology company) or other supplements that may be published and/or marketed. Thus, it is possible to use the automated system 1 to obtain a clonal population of cells.
In one embodiment, the one or more characteristics correspond to a measure of the number of cells within a cell culture vessel. The number of cells in a cell culture, e.g., cells in a colony tissue, may be a function of at least the area of a single cell, the area of the colony in which the single cell is included, and/or the degree of cell packing within the colony. In many cases it may be known that the area of a single cell of interest, the respective areas of a single cell and a cell colony, and the extent of the cell accumulation may all be calculated from one or more images (acquired using imaging module 100). In fact, a larger colony area and a high degree of cell packing in a cell colony corresponds to an increase in the number of cells in the colony, and correspondingly an increase in the number of cells in a cell culture.
Although the colony area may be calculated based on the original image or from a transformed representation of one or more images, quantifying the extent of cell packing presents greater challenges. The degree of cell packing can be determined based on the brightness of individual colonies because as the cell layer increases, less light can pass through, resulting in a relatively bright colony. In one embodiment, the switch expression may be presented in the form of a heat map from which the extent of cell stacking may be determined. In one embodiment, the original image of the one or more images may provide sufficient data on the apparent brightness of the colonies. In any event, after obtaining the necessary values, the number of cells in the cell culture vessel (or each colony therein) can be calculated. In embodiments where the particular cell culture is not susceptible to cell stacking, then the number of cells can be calculated without relying on determining the brightness of a single colony of the cell culture.
In fig. 8, there is shown: the average colony size (i.e., area) calculated based on one or more images corresponds to the average colony size (i.e., area) (R) determined using the Hoechst staining method20.86, p 0.94). Thus, a measure of colony size distribution in a cell culture (or between multiple cell cultures) can be determined from one or more images, and these one or more features can influence the operation of the system 1, alone or in combination with any other one or more features.
In FIG. 9It is shown that the total cell count within the cell culture vessel can be calculated based on one or more images acquired using imaging module 100, and that this calculation shows a good correlation with the total cell count obtained using manual methods (R)20.94, p < 0.0001). The determination of the total cell number based on one or more images is expressed in terms of raw intensity density, where the raw intensity density values are generated from one or more images of a live cell culture (i.e., raw images) based on the transformed expression of cell confluence.
In one embodiment, the one or more characteristics may correspond to a measure of the morphology of the cell culture within the cell culture vessel. The acceptable or unacceptable morphology of the cell culture can be determined by comparing the digital profile of the cell culture to known standards based on one or more images. For example, a Pluripotent Stem Cell (PSC) colony typically has a smooth-edged hemispherical shape, exhibiting tight cell packing and a high nuclear to cytoplasmic ratio. In contrast, differentiated Pluripotent Stem Cell (PSC) colonies, or those undergoing differentiation (PSC) colonies, deviate from the above characteristics. Thus, a digital profile of Pluripotent Stem Cell (PSC) colonies in a cell culture can be generated based on one or more images; and upon comparison to the criteria, the system 1 may execute an appropriate course of action via the at least one processor.
In one embodiment related to the above paragraph, the one or more characteristics may correspond to a measure of the degree of differentiation of the cell culture within the cell culture vessel. Based on one or more images, the consistency or inconsistency of the morphology of the cell culture (e.g., on a per colony basis or on an average basis) as compared to a standard may be indicative of the differentiation state of the cell culture. For example, if an experimental plan of differentiation is being performed using automated system 1 and the calculated one or more characteristics confirm the expected morphology of the cells at a particular point in time, it may not be necessary to deviate from the experimental plan. However, if, based on the calculated one or more characteristics, it is determined that the differentiation is less than expected or not, the system 1 may allow the test plan to continue to be developed to obtain further image(s), or the system 1 may perform a media change to introduce new differentiation media. In another example, if automated system 1 is performing an expansion experiment plan or a maintenance experiment plan for Pluripotent Stem Cell (PSC) culture, a significant degree of differentiation may trigger an intended passage experiment plan or terminate an experiment plan earlier.
In one embodiment, the determination of the differentiation state (or morphological change) of a cell culture may rely on one or more images and an equation or model derived from data using a machine-learned classifier (i.e., a trained machine-learned classifier). Fig. 10A and 10B show a representative image acquired by imaging module 100 and a representative image overlaid with undifferentiated, differentiated (lighter) and background (darkest) regions in fig. 10A, respectively. Fig. 10C shows the results of a classifier using three different classification models. Using the first classification model (which relies only on classifying undifferentiated colonies, ignoring predictors), a classification accuracy of 53.83% + -0.00% can be achieved. Using the second classification model, which assigns features to the classes with the highest correlation, i.e. undifferentiated, differentiated and background, a classification accuracy of 94.93% ± 0.08% can be achieved. Using a third classification model, which assigns features to classes, i.e., undifferentiated, differentiated and background, based on decision tree rules, a classification accuracy of 99.90% ± 0.02% can be achieved. The classifier used to generate the above data is trained by using a set of images, where background, undifferentiated Pluripotent Stem Cell (PSC) and differentiated Pluripotent Stem Cell (PSC) regions are manually selected among a subset of one or more images. The set of training images does not include the test images in fig. 10. Training and experiments of classifiers were performed using WEKA Workbench. See, e.g., ien H vitta (Ian h.witten) and ibe Frank (Elbe Frank) (2005), "data mining: practical machine learning tools and techniques (Data Mining: Practical machine learning tools and techniques), second edition, Morgan Kaufmann publishers, san Francisco 2005.
Since cells of the ectodermal, endodermal and mesodermal lineages each exhibit a unique morphology, trained machine learning classifiers are also possible to make this distinction based on one or more images.
In embodiments of systems or methods for performing a Pluripotent Stem Cell (PSC) maintenance experimental plan as disclosed herein, it is also possible to selectively passage undifferentiated Pluripotent Stem Cells (PSCs), leaving colonies in the cell culture vessel that exhibit a higher degree of differentiation (fig. 11). For example, when the system 1 initiates a passaging experiment plan in response to a command issued by the at least one processor 600, the pipette module 200 may aspirate cell culture medium from the cell culture vessels (whether or not dependent on the tilting function of the stage module 500), while the liquid dispenser module 300 may dispense an amount of wash buffer into the cell culture vessels (which is then aspirated using the pipette module 200). A specialized cell separation fluid, such as ReLeSR, may be usedTM(Stem cell technology company) into the cell culture vessel to selectively strip undifferentiated Pluripotent Stem Cell (PSC) colonies from the cell culture vessel. The time of exposure to the cell separation fluid can be adjusted according to a measure of differentiation of the cell culture. For example, in assessing highly differentiated conditions, a shorter culture time may reduce the proportion of differentiated colonies that become exfoliated. Thus, seeding with a cell suspension of a detached colony derived only from undifferentiated Pluripotent Stem Cells (PSCs) allows for enrichment of undifferentiated Pluripotent Stem Cells (PSCs) in progeny cell culture vessels. Also, in performing the differentiation experimental plan, such exfoliated colonies of undifferentiated Pluripotent Stem Cells (PSC) may be discarded, and the remaining differentiated colonies may be dissociated and then passaged.
In one embodiment, the one or more features may correspond to a calculated measure of change of the one or more features from a first point in time relative to one or more subsequent points in time. For example, the one or more characteristics can be a measure of the degree of fusion of the cell culture at a first time point versus a second time point.
Fig. 12 illustrates the determination of a planning time for a passaging experiment performed using automated system 1, which may be based on the calculation of the fusion of a cell culture at a first time point and one or more subsequent time points. Therefore, extrapolating the above data to one maximum or desired passaging fusion for any cell culture can help to schedule passaging experimental plans, particularly when automated system 1 is responsible for up to several hundred plates at any one point in time.
In one embodiment, the one or more features may correspond to a metric of one of the one or more features (as a function of another one of the one or more features). For example, the one or more characteristics may be a measure of the degree of fusion of the cell culture (as a function of the degree of differentiation of the cells or colonies of the cell culture), and vice versa. The characteristics of the one or more characteristics may also be assessed at a first point in time and at one or more subsequent points in time.
Based on the acquisition and analysis of all data points (associated with the calculation of the one or more features), the system 1 is able to learn (i.e., train) itself, and does not require the operator to provide instructions as to when to perform automatic passaging or other experimental planning. Thus, the presently disclosed subject matter may relate to systems and methods for adaptively passaging a cell culture.
As used herein, "adaptively passaged" refers to a flexible experimental plan for passaging, and its execution relies on one or more features calculated based on one or more images acquired at one or more time points. Furthermore, such subculture plans do not necessarily rely on prompts from the operator of the system 1. In contrast, system 1, having processed one or more images (taken at one or more time points) and calculated one or more characteristics, may perform a passaging experiment plan (or an expansion experiment plan or a differentiation experiment plan) with an appropriate number of cells at an appropriate time to obtain or maintain a consistent cell culture at each subsequent passage (e.g., without limitation, in a routine maintenance culture of the cell culture or in an uploading operation of a newly derived or obtained cell line).
In one embodiment, at a first point in time or at one or more subsequent points in time, the one or more characteristics calculated for the cell culture in the cell culture vessel are different from the second cell culture in the second cell culture vessel and become more consistent during a subsequent passage based on the operation of system 1. For example, if the confluency of a first cell culture in a first cell culture vessel or in a first well thereof is 25% at a first point in time (e.g., day 6 of passage 0), and the confluency of a second cell culture in said second cell culture vessel, e.g., in a second well of said first cell culture vessel, is 10% at a first point in time, this will result in an asynchronous auto-passaging experimental plan being performed. Performing asynchronous auto-passaging experimental programs may be undesirable in terms of efficiency, but if, for example, a first cell culture and a second cell culture are in different wells of the same cell culture vessel, one cell culture may be exposed to unnecessary risk because the other cell culture is being passaged. Thus, automated system 1 may adaptively adjust one or more elements of one subsequent passage, e.g., seeding density, of both the first and second cell cultures so that the degree of fusion of the first and second cell cultures becomes more consistent at a subsequent time point (e.g., day 6 of the 0+ n passage).
Fig. 13 shows that the fusion degree variation of multiple cell cultures is relatively large in multiple cell culture vessels, and can become more consistent after adaptive passaging experimental planning using system 1. After the relationship between the degree of confluency of the parent cell culture vessel and the degree of confluency of the daughter cell culture vessel is determined, it is possible to calculate the appropriate dilution (i.e., seeding density) of the cell suspension to inject into one daughter or granddaughter cell culture vessel.
The at least one processor of system 1 is further configured to execute an automated passaging experiment plan to passage the cell culture, the experiment plan including coordinating operation of at least imaging module 100, pipette module 200, liquid dispenser module 300, and processing module 400 based on the calculated comparison of the one or more characteristics of the cell culture to known or input threshold levels of the one or more characteristics of the cell culture.
Upon acquiring the one or more images, automated system 1 (which is communicatively coupled to the at least one processor 600 of the imaging module) calculates the one or more characteristics of the cell culture based on the one or more images. In one embodiment, the calculation of the one or more features may be done according to the above description. In particular, the one or more features may include:
a) a measure of the degree of fusion of the cell culture;
b) a measure of the morphology of the cells or colonies of the cell culture;
c) a measure of differentiation of cells or colonies of the cell culture;
d) a measure of the size distribution of the colonies of the cell culture;
e) a), b), c) or d) a measure of change from the first point in time to the one or more subsequent points in time; or
f) a) a measure relative to b), c) or d), b) a measure relative to a), c) or d), c) a measure relative to a), b) or d), or d) a measure relative to a), b) or c).
After calculating the one or more characteristics, automated system 1 executes (by at least one processor 600) an automated passaging experiment plan based on comparing the calculated one or more characteristics of the cell culture to a known or input threshold level of the one or more characteristics of the cell culture.
In one embodiment, the known or input threshold level ranges from about 30-90% for a measure of the degree of fusion of a cell culture (i.e., cells or colonies). Thus, if the cell culture has reached a confluency of between about 30-90%, automated system 1 may initiate a passaging experiment plan. In one embodiment, a measure of the degree of fusion of a cell culture (i.e., a cell or colony) is in the range of about 40-80%. In one embodiment, a measure of the degree of fusion of a cell culture (i.e., a cell or colony) is in the range of about 50-70%.
In one embodiment, the known or input threshold level is about ± 30% of a control cell culture with respect to a measure of morphology of a cell culture (i.e., cells or colonies). Thus, if a cell culture deviates by between about ± 30% from a control cell culture with respect to its morphology, automated system 1 may initiate a passaging experimental plan. In one embodiment, the measure of morphology of the cell culture (i.e., cells or colonies) is about ± 20% of the control cell culture. In one embodiment, the measure of morphology of the cell culture (i.e., cells or colonies) is about ± 10% of the control cell culture.
In one embodiment, the known or input threshold level is between about 0 and 30% of a control culture in a maintenance protocol or between about 50% -100% of an uncontrolled culture in a differentiation protocol, as a measure of the differentiation level of a cell culture (i.e., cells or colonies). In one aspect, an automated system 1 passaging experimental plan may be initiated if a differentiation level of about 0-30%, or about 10-20%, or about 15% has been reached in the cell culture relative to a control culture that maintains the experimental plan. In contrast, if the cell culture has reached a level of differentiation of about 0-30%, or about 10-20%, or about 15% relative to a control culture in a differentiation protocol, automated system 1 may not initiate a passaging protocol. In contrast, in this case, the automated system 1 may do nothing or replace spent differentiation medium with fresh differentiation medium. On the other hand, if the cell culture achieves a level of differentiation of about 50-100%, or about 60-90%, or about 70-80%, or about 75% relative to the control culture in the differentiation protocol, automated system 1 can initiate a passaging (and/or expansion) protocol, or harvest the differentiated cells for downstream use. Conversely, if the cell culture has reached a level of differentiation of about 50-100%, or about 60-90%, or about 70-80%, or about 75% relative to the control culture in the maintenance experiment plan, automated system 1 may initiate a passaging experiment plan to try and resuscitate the cell culture or terminate the experiment plan.
In one embodiment, the known or input threshold level is within about 20% or about 15%, or about 10% or about 5% or a sub-fraction thereof of the average colony size of the control culture, as measured by the colony size distribution of the cell culture (i.e., cells or colonies). Thus, system 1 may initiate a passaging experimental plan if the mean colony size distribution of the cell culture is within about 20% or about 15% or about 10% or about 5% or a sub-fraction thereof of the mean colony size distribution of the control culture. In one embodiment, a threshold level that is within about 20% or about 15%, or about 10% or about 5% of the mean colony size distribution of the control culture falls within a sub-fraction of the colony size distribution, e.g., the first 10%, or the first 20% or the first 30% or the first 40%, or the second 10%, or the second 20%, or the second 30%, or the second 40%.
System 1 may also include a housing 700 to house at least pipette module 200, liquid dispenser module 300, processing module 400 and stage module 500, pipette tip holders 225 and 230, and carriage 220 (in embodiments that include these). The imaging module 100 and camera 105 may also be housed in the housing 700 (fig. 3B), but may also be included elsewhere, such as in an incubator module (described below).
In one embodiment, the housing 700 maintains a sterile internal environment. In one embodiment, the housing 700 may correspond to one aseptic chamber. In such embodiments, all of the modules of the disclosed system 1 may be included in the sterile room. In one embodiment, the housing 700 may correspond to a biosafety cabinet. In such an embodiment, due to space constraints, the modules located therein should be limited to the modules that perform the automated passaging (or other) experimental plan.
In one embodiment, more than one accumulator 350, one refrigeration module 800, and one waste reservoir 900 are located outside of the housing 700.
The system 1 may also include a refrigeration module 800 to store one or more of the one or more reservoirs 350. The refrigeration module 800 is used to store one or more of the one or more reservoirs 350 at a desired temperature. For example, a cell culture medium should be stored at around 4 ℃ to limit degradation of its contents. Similarly, cell separation solutions, wash buffers, and certain cell culture matrix solutions also need to be stored at around 4 ℃.
The refrigeration module 800 may include one or more sensors. In one embodiment, one first sensor detects and reports (to at least one processor 600) a mass for each of the above reservoirs 350. Thus, the first sensor provides real-time feedback to the system 1 that an appropriate volume of solution has been dispensed from the first reservoir. Without this feedback, the system 1 may determine a calibrated volume of solution to be dispensed from the first reservoir. In the same or a different embodiment, a second sensor detects and reports (to at least one processor 600) the temperature within the refrigeration module 800. Thus, the second sensor provides real-time feedback to the system 1 regarding the refrigeration module 800 being maintained at the proper temperature.
The system 1 may also include a waste reservoir 900 (see fig. 1). Waste reservoir 900 may be in fluid communication with a waste tank 925 located within housing 700. The design and location of the waste tank is an important consideration in order to minimize the possibility of contamination of the cell culture or other components within the system 1, whether by unwanted solutions or microorganisms. Fig. 14A and 14B illustrate one embodiment of a waste chute 925.
In one embodiment, waste tank 925 may be remote from imaging module 100, liquid dispensing module 300, and stage module 500. In one embodiment, the waste tank 925 may be located below the liquid dispenser module 300 to simplify the process of removing cell culture solution from (i.e., purging old or room temperature solution from) one or more conduits of the liquid dispenser module 300 during start-up operations.
Waste tank 925 includes a channel 930 for delivering a solution to waste reservoir 900. In one embodiment, the waste chute includes a first chute 935 and a second chute 937, both of which are in fluid communication with the channel 930. The first slot 935 may receive emissions from the pipette module 200, and the second slot may receive emissions from the liquid dispenser module 300, and more specifically, the one or more conduits associated therewith.
In one embodiment, the first tank 935 further includes a rinse inlet 938 for providing a solution (e.g., a sanitizing solution). One skilled in the art would know of suitable disinfection solutions useful in cell culture processes. For example, the disinfecting solution may be a dilute bleach. Alternatively, the disinfecting solution may be an alcohol (e.g., an isopropyl alcohol).
In one embodiment, waste tank 925 may include a geometry that minimizes pooling of solutions discharged therein. In one embodiment, a receiving surface 940 of waste tank 925 may be sloped downward toward passageway 930 to encourage the drainage solution through passageway 930. In one embodiment, the receiving surface 940 may also include a pair of sloped walls that converge to a point or substantially a point formed on the receiving surface 940. In such embodiments, the pair of converging walls cooperate with the downward slope to urge the discharged solution toward and through the channel 930.
In one embodiment, waste tank 925 also includes a level sensor 945 to detect and report (to at least one processor 600) on the accumulation of waste reservoir 900 or the blockage of passage 930.
In one embodiment, waste tank 925 can be coated with a hydrophobic coating or a superhydrophobic coating. In one embodiment, the coating may be based on silica nanoparticles. Those skilled in the art will recognize other suitable hydrophobic or superhydrophobic coatings such as silicone or perfluorocarbon based coatings, and the like.
In one embodiment, waste trough 925 can occupy a relatively small footprint to minimize a large open area where residual solution (such as cell culture media) can collect and create potential contamination issues. In one embodiment, waste chute 925 further includes a cover 950 to further reduce the open area without reducing its capacity.
The system 1 may also include an incubator module 1000, wherein the incubator module maintains allowable environmental conditions for culturing cells, such as pluripotent stem cells. Incubator modules are known in the art and may be purchased (e.g., from Liconic). In one embodiment, incubator module 1000 may include shelves for multiple cell culture vessels. In one embodiment, incubator module 1000 further comprises a processing device for selectively withdrawing a cell culture container from a rack, and such processing device's selective withdrawal of the cell culture container is based on a unique identifier (i.e., a bar code and bar code reader) associated with the cell culture container.
In one embodiment, the incubator module 1000 includes one or more sensors to detect and report (to at least one processor 600) on temperature or humidity such as, for example, and CO such as2% other atmospheric conditions.
If the system 1 includes one incubator module 1000, it may be desirable to include a conveyor module 1150 for connecting the housing 700 and the incubator module 1000 and for conveying the cell culture vessels from the incubator module 1000 to the vicinity of the processing module 400 (FIG. 1). In one embodiment, conveyor module 1150 may be closed to prevent exposure of the cell culture vessel to a non-sterile environment.
Both the incubator module 1000 and the conveyor 1150 are communicatively coupled to at least one processor 600. For the incubator module 1000, the at least one processor 600 may initiate whether the command is to: engaging the processing device to selectively withdraw one of the cell culture vessels from the rack or replace one of the cell culture vessels; or to adjust atmospheric conditions therein. With respect to the transmitter module 1150, the at least one processor 600 may initiate whether the command is to: transporting a cell culture container out of the incubator module 1000; or a cell culture container is transported from, for example, housing 700 to the incubator module.
The system 1 may also optionally include a controller 700 for coordinating the operation of each module of the automation system. The controller 700 includes software (the software may be included in a personal computer). The software in the controller 700 is capable of executing commands necessary to coordinate the operation of each module of the automation system.
The system 1 may also include a graphical user interface 1200 (communicatively coupled to the at least one processor). The graphical user interface 1200 is preferably located outside of the housing 700. In one embodiment, graphical user interface 1200 is a display of a personal computer integrated with system 1. In one embodiment, the graphical user interface 1200 is a display of a personal computer that is wirelessly connected to the system 1. The graphical user interface 1200 may provide the user of the system 1 with the necessary controls to direct the operation of the system 1, such as scheduling an automated cell culture process, viewing the automated cell culture process performed by the system 1, viewing the one or more images acquired by the camera 105, receiving notifications or status from each of the sensors integrated into the system 1, and viewing a liquid level report for each of the one or more reservoirs 350.
The system 1 may also include a dissociation module 1300 according to an apparatus for dissociating one or more colonies in a cell culture described below. The cell culture container may be transported to the dissociation module 1300 using the processing module 300.
Method of using the system
In another aspect of the invention, automated system 1 may be used to perform an automated method of passaging a cell culture (fig. 15). In one embodiment, automated system 1 may be used to perform an automated method of adaptively passaging a cell culture. In particular embodiments, the cell may be a pluripotent stem cell, and even more particularly, the cell may be a human pluripotent stem cell. Since it is desirable in many applications to passage human pluripotent stem cells in the form of clumps or clusters, automated methods of passaging human pluripotent stem cell cultures may be suitable for cluster passage thereof.
The methods disclosed herein may be used to passage a cell culture, but they are not so limited. Variations of the method can be used to perform medium exchanges as part of a routine maintenance experiment plan. Alternatively, the method may be used to perform a cell expansion protocol in which the cell culture may be cultured continuously, into larger culture vessels or into a larger number of wells. Alternatively, the method may be used to perform an upload experiment plan for a new cell line, for example a newly derived or obtained Pluripotent Stem Cell (PSC) cell line, in which the collection and analysis of data at early passages (i.e. the characteristic (s)) may inform about the optimal conditions for performing subsequent passages. Alternatively, the method may be used to perform a cell differentiation protocol in which a starting cell population is exposed to differentiation conditions (e.g., a differentiation medium) to convert the starting cell population to a derived cell lineage. Specific examples of pluripotent stem cells include cells that differentiate into ectodermal layered or ectodermal cells, into endodermal layered or endodermal cells, or into mesodermal or mesodermal cells upon exposure of the cells to a suitable culture medium.
The automated method for passaging a cell culture comprises providing the cell culture in a cell culture medium within a cell culture vessel. In one embodiment, providing the cell culture comprises transferring the cell culture from an incubator. The transfer of the cell culture containers may be accomplished using a conveyor device, such as the conveyor module described above. In one embodiment, providing the cell culture vessel (and the cell culture therein) may be accomplished by using a cell culture vessel processor (e.g., the processing module described above).
In one embodiment, the automated method, and more particularly, the automated method of providing the cell culture vessel (and the cell culture therein), may further comprise placing the culture vessel on a stage (e.g., the stage module described above). In one embodiment, the placement of the cell culture container may be accomplished using the cell culture container processor (i.e., the processing module).
The automated method further comprises acquiring, by an imaging module, one or more images of the cell culture at a first point in time and at one or more subsequent points in time. In one embodiment, the imaging module is substantially as described above.
Upon acquiring the one or more images, the automated method further comprises calculating, by at least one processor communicatively coupled to the imaging module, one or more characteristics of the cell culture, the calculating based on the one or more images. In one embodiment, the calculation of the one or more features may be done according to the description above. In particular, the one or more features may include:
a) a measure of the degree of fusion of the cell culture;
b) a measure of the morphology of the cells or colonies of the cell culture;
c) a measure of differentiation of cells or colonies of the cell culture;
d) a measure of colony size distribution of the cell culture;
e) a), b), c) or d) a measure of change from the first point in time to the one or more subsequent points in time; or
f) a) a measure relative to b), c) or d), b) a measure relative to a), c) or d), c) a measure relative to a), b) or d), or d) a measure relative to a), b) or c).
After calculating the one or more characteristics, the automated method further comprises executing, by the one or more processors, an automated passaging experiment plan based on comparing the calculated one or more characteristics of the cell culture to a known or input threshold level of the one or more characteristics of the cell culture.
In one embodiment, the known or input threshold level ranges between about 30-90% for the degree of fusion of a cell culture (i.e., cells or colonies). Thus, if the cell culture has reached a confluency of between about 30-90%, automated system 1 may initiate a passaging experiment plan. In one embodiment, a measure of the degree of fusion of a cell culture (i.e., a cell or colony) is between about 40-80%. In one embodiment, a measure of the degree of confluency of a cell culture (i.e., a cell or colony) is between about 50-70%.
In one embodiment, the known or input threshold level is about ± 30% of a control cell culture with respect to a measure of morphology of a cell culture (i.e., cells or colonies). Thus, if the cell culture deviates by approximately between ± 30% from a control cell culture in terms of its morphology, automated system 1 may initiate a passaging experiment plan. In one embodiment, the measure of morphology of a cell culture (i.e., cells or colonies) is between about ± 20% of a control cell culture. In one embodiment, the measure of morphology of a cell culture (i.e., cells or colonies) is approximately between ± 10% of a control cell culture.
In one embodiment, the known or input threshold level is about between 0-30% of a control culture in a maintenance protocol or about 50% -100% of a control culture in a differentiation protocol, as a measure of the differentiation level of a cell culture (i.e., cells or colonies). In one aspect, automated system 1 may initiate a passaging experimental plan if a differentiation level of between about 0-30%, or between about 10-20%, or between about 15% has been reached in the cell culture relative to a control culture that maintains the experimental plan. In contrast, automated system 1 may not initiate a passaging experiment plan if the cell culture has reached a differentiation level of between about 0-30%, or between about 10-20%, or about 15% relative to a control culture in a differentiation experiment plan. In this case, the automated system 1 may do nothing or replace spent differentiation medium with fresh differentiation medium. On the other hand, if the cell culture achieves a level of differentiation of between about 50-100%, or between about 60-90%, or between about 70-80%, or between about 75% relative to a control culture in a differentiation protocol, automated system 1 may initiate a passaging (and/or expansion) protocol or harvest the differentiated cells for downstream use. Conversely, if the cell culture has reached a level of differentiation of between about 50-100%, or between about 60-90%, or between about 70-80%, or about 75% relative to a control culture in a maintenance protocol, automated system 1 may initiate a passaging protocol to try and revive the cell culture or a termination protocol.
In one embodiment, the known or input threshold level is within about 20% or about 15%, or within about 10% or about 5%, or a sub-fraction thereof, of the average colony size of a control culture, with respect to a measure of the colony size distribution of a cell culture (i.e., cells or colonies). Thus, system 1 may initiate a passaging experimental plan if the mean colony size distribution of the cell culture has reached within about 20%, or within about 15%, or within about 10%, or within about 5%, or a sub-fraction thereof, of the mean colony size distribution of a control culture. In one embodiment, the threshold level that is within about 20%, or about 15%, or about 10% or about 5% of the mean colony size distribution of a control culture falls within a sub-fraction of the colony size distribution, e.g., the first 10%, or the first 20%, or the first 30% or, the first 40%, or the second 10%, or the second 20%, or the second 30%, or the second 40%.
As used herein, "an automated passaging experimental plan" refers to the culturing activities up to the point in time at which a cell culture can be propagated (e.g., by subculture), as well as the activities necessary to achieve the subculture of a cell culture, including the inoculation of part or all of the cell culture into one or more daughter cell culture vessels. Thus, the term passaging is intended to include activities associated with the routine culturing of cells, such as subculture of cell cultures, and workflow directed to expanding or differentiating cell cultures.
In one embodiment, the performance of a passaging protocol may be accomplished by obtaining a cell suspension from the cell culture and seeding a progeny cell culture vessel with a portion or all of the cell suspension.
In one embodiment, obtaining the cell suspension further comprises passing the cell suspension through a first pipette tip to dissociate the cell culture into a single cell suspension or clusters having an average diameter that does not exceed the pore size of the first pipette. In one embodiment, the cell suspension may be passed through the first tip using the pipette module described above.
The medium in the first cell culture vessel may be removed by aspirating the medium from the cell culture vessel or well thereof prior to obtaining the cell suspension. As described above, in one embodiment, the cell culture medium may be aspirated using the pipette module described above. In one embodiment, removing (i.e., aspirating) the cell culture medium may comprise tilting the first cell culture vessel, followed by aligning a pipette tip that mates with a pipette of the pipette module with a lower corner of the cell culture vessel or a well thereof.
After aspirating the medium, it may be desirable to perform a wash step by dispensing a wash buffer into the cell culture vessel or its wells. In one embodiment, the liquid dispensing module described above may be used to dispense wash buffer. Thereafter, the wash buffer may be aspirated (i.e., removed), e.g., via the pipette module, as described above.
If a seeding experiment plan is being performed, fresh media may be added to the cell culture vessel or all of its appropriate wells (after aspiration of spent media and/or washing) before returning the cell culture vessel to an incubator (the incubator module as described above).
In the methods associated with passaging or expanding cells, the cell culture in the cell culture vessel (from which the cell culture medium has been removed and optionally has been subjected to a washing step) may be contacted with a stripping/dissociation solution. Any suitable stripping or dissociation solution may be used to contact the cell culture in the cell culture vessel or well thereof. In one embodiment, the separation liquid may be ReLeSRTM(Stem cell technology Co.) or STEMdiffTMNeural Rosette selection reagent (stem cell technologies). In one embodiment, the dissociation solution may be GCDR (stem cell technology) or some other trypsin-based solution. Contacting of the cell culture in the cell culture vessel with a stripping or dissociation solution may be carried out using the liquid dispensing module as described above. Depending on the type of solution used, the cell culture may be incubated in the presence of the stripping or dissociation solution at 37 ℃ or room temperature for a sufficient period of time. Also depending on the type of solution used, it may be desirable to aspirate the solution prior to incubating the cell culture. Further, depending on the type of solution and cell type used, it may be desirable to transport the cell culture container to the incubator module.
In one embodiment, the separation solution is a dissociation solution, and the dissociation solution selectively separates a first set of differentiated cells or a second set of undifferentiated cells from a wall of the cell culture vessel. In such embodiments, depending on the application, a ReLeSR may be usedTM(Stem cell technology Co.) or STEMdiffTMNeural Rosette selection reagent (stem cell technologies).
Following incubation of the first cell culture vessel, subsequent steps of the method may include: the first cell culture container is transported to the dissociation module (described below) using the processing module, and a cell colony (such as, but not limited to, a pluripotent stem cell colony) is detached from a bottom of the well of the first cell culture container using the dissociation module.
As described above, some or all of the one or more cell colonies may be exfoliated by an exfoliation/dissociation solution, or it may be necessary to use the dissociation module to cause some or all of the one or more cell colonies to exfoliate. In any event, activation of the dissociation module may also assist in dissociating the exfoliated cell colonies into a cell suspension, and in one embodiment into a cluster suspension of pluripotent stem cells.
In some embodiments, fragmenting the cell suspension using the pipettor module before or after activating the dissociation module may facilitate dissociation of the one or more colonies into a cell suspension, e.g., a cluster suspension of pluripotent stem cells.
After dissociating the one or more cell colonies into a cell suspension, a volume of the cell suspension (whether a single cell suspension or multiple cluster suspensions) may be seeded into a progeny cell culture container or well thereof, for example, by the pipette module.
In one embodiment, the automated process can further comprise dispensing a first solution and a second solution simultaneously or sequentially in a progeny cell culture vessel before or after seeding a volume of the cell suspension into the progeny cell culture vessel. In one embodiment, the first solution is the cell culture medium and the second solution is a solubilized extracellular matrix.
For an expansion experiment, some or all of the cell suspension may be seeded into a second culture vessel that is larger than the first culture vessel, or into a plurality of wells of the second culture vessel.
Device for measuring the position of a moving object
In one aspect of the invention, there is provided a device for exfoliating or dissociating one or more colonies present in a cell culture (see fig. 16). Throughout the present invention, the apparatus 2 may also be referred to as a dissociation module.
As used herein, the term "cell" refers to any type of cell (whether ex vivo or in vitro) that is capable of being cultured. Cells may be important to grow as adherent cultures, but cells grown in suspension are also within the scope of the invention. The source of the cells may be mammalian, and in some cases, the cells may be human cells. The cell may also be a pluripotent stem cell, and in some embodiments, the cell may be a human pluripotent stem cell. In some embodiments, the cells are one or more undifferentiated colonies in a pluripotent stem cell culture. Undifferentiated pluripotent stem cells can be cultured as a monolayer or in suspension, and upon division, they form colonies or aggregates, respectively. Undifferentiated pluripotent stem cells are cells that are capable of self-renewal and can differentiate into any lineage. For example, a pluripotent stem cell may be an embryonic stem cell, an induced pluripotent stem cell, or other types of cells found in the art, examples of which include expanded pluripotent stem cells. Many pluripotent stem cell lines are known, but it is common to create new pluripotent stem cell lines using existing scientific techniques.
In one embodiment of the device 2 for dissociating one or more colonies in a cell culture, the device comprises a rotatable drive 5, the rotatable drive 5 being connected to a mounting surface 10 (see figure 16). The rotatable drive 5 may comprise any known means of converting electrical energy into rotational motion. In one embodiment, the rotatable drive 5 comprises a motor 15 (see fig. 17) connected to a rotatable shaft 20. The driver 5 may be connected to one top surface of the mounting surface 10, and the motor 15 and the rotatable shaft 20 may protrude upward from one horizontal surface of the mounting surface 10. Accordingly, the rotatable drive 5 or its rotatable shaft 20 is rotatable about a first axis perpendicular or substantially perpendicular to the mounting surface 10.
The apparatus 2 also includes a platform 25 for supporting a cell culture container. The platform 25 is connected to the drive 5, and more specifically to the end 22 of the rotatable drive 5, and still more specifically to the end 22 of the rotatable shaft 20 (see fig. 17).
Platform 25 may be substantially planar to support a bottom surface of a cell culture container (not shown). Platform 25 may be of any size so long as it can support at least one cell culture container on its top surface. Many types of cell culture vessels are known in the art, and all of these are contemplated in the present invention. In general, the cell culture vessel may be any vessel capable of containing cells for culture thereof. By way of non-limiting example, the cell culture vessel may be a microplate, such as, but not limited to, a 6-well plate, a 12-well plate, a 24-well plate, or a 96-well plate. Alternatively, the cell culture vessel may be a cell culture flask, such as, but not limited to, a T-flask. In some embodiments where the cell culture vessel is a T-flask, the platform may be sized appropriately to support, for example, a T25 flask, a T75 flask, a T150 flask, a 175 flask, or a T225 flask. Alternatively, the cell culture container may be a cell culture dish, such as, but not limited to, a petri dish, a 35mm dish, a 10mm dish, or a larger dish.
In one embodiment, the platform 25 is biasedly connected to the driver 5 or the end 22 thereof. For example, as previously described, the drive 5 or its end 22 may define a first axis of rotation, and the platform 25 may be rotatable about a second axis of rotation (passing through the center of rotation of the platform 25). In some embodiments, the driver 5 or its end 22 may be coupled to the platform 25 at a position offset from said center of rotation of the platform 25. In case the platform 25 is connected offset to the drive 5, the platform 25 will have a wider trajectory around said first axis, i.e. said axis of rotation of the drive 5 or its end 22, than in case the drive 5 or its end 22 is coupled to the centre of rotation of the platform 25.
In the same or a different embodiment, the platform 25 may also be indirectly connected to the drive 5. In such embodiments, the device 1 may also include a spacer 27 that attaches the platform 25 to the drive 5 in the middle. The spacer 27 may be any component that intermediately attaches the platform 25 to the drive 5 while still allowing the platform 25 to rotate depending on or independent of the rotatable drive 5. In the preferred embodiment, the spacer 27 is a bearing.
In embodiments where the platform 25 is indirectly and offset connected to the drive 5, the spacer 27 may alternatively be referred to herein as an eccentric spacer. As shown in fig. 18, the spacer 27 may be connected to the actuator 5 at a first position 28 thereof and to the platform 25 at a second position 29 thereof. In a particular embodiment where the spacer 27 is a bearing, the drive 5 may be connected to a first race (i.e., an inner race) of the spacer 27 and the platform 25 may be connected to a second race (i.e., an outer race) of the spacer 27. Correspondingly, a first position 28 corresponds to the inner race and a second position 29 corresponds to the second race.
In embodiments where the spacer 27 is a bearing and the platform 25 is connected to an outer race of the spacer 27, the platform 25 is rotatable about a second axis offset from the first axis. In some embodiments, the second axis may pass through a center of rotation of the platform 25. In other embodiments, the second axis may pass through a point other than the center of rotation of the platform 25. The first axis and the second axis may be offset by any distance as long as their geometry allows the operation of the device 1 and the insertion of its elements (i.e. the impact bracket(s) and the impact bumper(s) to be described in detail below). In particular embodiments, the first axis (i.e., the first position) and the second axis (i.e., the second position) are offset by about 4mm, about 4.5mm, about 5mm, about 5.5mm, about 6mm, about 6.5 mm, about 7 mm, about 7.5 mm, about 8 mm, about 8.5 mm, about 9 mm, about 9.5 mm, or about 10 mm.
In some embodiments, platform 25 may also include guides 30 (guides 30 help place the cell culture vessel thereon). The guide 30 may correspond to a protrusion, such as but not limited to a pin or ridge, rising upward from one of the top surfaces of the platform 25. In addition to facilitating placement of the cell culture container on platform 25, guide 30 may also facilitate securing the cell culture container on platform 25 during operation of device 2.
In embodiments where the platform 25 is quadrilateral, the guides 30 may be located at one or more corners of the platform 25. In some embodiments, the guides 30 may be located at least two corners of the platform 25. In a more preferred embodiment, the guides 30 may be located at all four corners of the platform 25.
In embodiments where the platform 25 is not quadrilateral, the guides 30 may simply be suitably configured to facilitate placement of the cell culture container and, optionally, to secure the cell culture container to the platform 25.
The apparatus 1 may also include one or more impact brackets 35 connected to the platform 25. The impact bracket 35 may be attached to any portion of the platform 25, such as, but not limited to, one or more edges thereof or a bottom surface thereof. If the footprint of the cell culture vessel is larger than the surface area of platform 25, it is important to ensure that the top surface of impact cradle 35 does not protrude above the upper plane of platform 25.
The impact bracket 35 may be made of any material, but in order to minimize or prevent excessive wear and noise, it is desirable to make the impact bracket 35 from rubber or a rubber-like substance, and preferably, from a relatively dense rubber or rubber-like substance. Alternatively, the impact bracket 35 may be made of a stronger and more durable material, such as, but not limited to, metal or metalloid, and optionally covered with rubber or rubber-like substances at the impact site.
In one embodiment, the apparatus 2 includes two impact brackets 35a and 35 b. Impact brackets 35a and 35b may be attached to the bottom surface or opposite edges of platform 25. Wherever the impact brackets 35 (including impact brackets 35a and 25b) are attached to the platform 25, it is only important that they can contact one or more impact bumpers 40 attached to the mounting surface 10.
Shock absorber 40 is generally coupled to an upper surface of the mounting surface 10 and extends axially from the mounting surface 10 toward a bottom surface of the platform 25. In some embodiments, particularly when the impact bracket 35 is coupled to a bottom surface of the platform 25, the impact bumper 40 generally extends toward a bottom surface of the platform 25 for a distance (which is less than the spacing between the mounting surface 10 and the platform 25).
The impact bumper 40 may be made of any material, but in order to minimize or prevent excessive wear and noise, it is desirable to make the impact bumper 40 from a rubber or rubber-like substance, and it is preferable to make the impact bumper 40 from a relatively dense rubber or rubber-like substance. Alternatively, the impact bumper 40 may be made of a stronger and more durable material, such as, but not limited to, metal or metalloid, and optionally covered with rubber or rubber-like substances at the impact site.
In one embodiment, the apparatus 2 includes four impact bumpers 40a, 40b, 40c and 40d disposed on the mounting surface 10 to define a quadrilateral. The shock absorbers 40a, 40b, 40c and 40d are provided to ensure that the stroke of any one shock bracket (e.g., 35a or 35b) is limited by two shock absorbers (e.g., 40c and 40d or 40a and 40b), respectively. In the case where the stroke of either impact bracket is limited by two impact bumpers, the stroke of the impact bracket (and hence the platform) is limited between the two impact bumpers.
Referring to FIG. 19, one exemplary arrangement of impact brackets 35a and 35b and impact bumpers 40a, 40b, 40c and 40d is shown. By way of example only, the impact bracket 35a collides with the impact bumper 40c when the platform 25 (not shown in fig. 19) is rotated in a given direction under the direct influence of the driver 5. By means of the spacer 27, the bracket 35a can, independently of the rotation of the driver 5, spring back towards the impact damper 40d and possibly come into contact therewith. The same dynamics occur in the impact bracket 35b and the impact bumpers 40a and 40 b.
Thus, when the platform 25 is rotated under the influence of the driver 5, one or more impact bumpers 40 are attached to the mounting surface 10 and accessible to the one or more impact brackets 35. Repeated collisions of one or more impact brackets 35 with one or more impact bumpers 40 transmit force to platform 25 and to any cell culture vessels above platform 25, including the contents contained therein. Such agitation or impact forces may cause one or more colonies of the cell culture contained in the cell culture vessel to be dissociated into smaller units, such as, but not limited to, clumps or clusters of cells.
The apparatus 2 may also include a controller (which regulates the output of the driver 5). By manipulating the controller, it is adjustable: the direction of rotation of the drive 5, the speed of rotation of the drive 5; and the rotational acceleration of the driver 5. In a particular embodiment, the direction of rotation of the driver 5 may be clockwise. In other embodiments, the direction of rotation of the driver 5 may be counter-clockwise. In a more specific embodiment, the direction of rotation of the driver 5 may be clockwise or counterclockwise. In yet a more specific embodiment, the direction of rotation of the driver 5 may be regularly alternated between clockwise and counterclockwise.
The device 2 may also include sensors, such as an accelerometer or optical marker sensor, to receive feedback regarding the operation of the device.
The apparatus 2 may further comprise a home sensor to provide orientation of the platform.
Method for using device
In another aspect of the invention, device 2 may be used in a method of dissociating one or more colonies in a cell culture. In one non-limiting embodiment, the cell culture can be a culture of pluripotent stem cells contained in one or more colonies. In a more specific non-limiting embodiment, the one or more colonies in a cell culture can be one or more undifferentiated colonies in a pluripotent stem cell culture, and optionally, wherein the pluripotent stem cells are human.
In other aspects of the invention, device 2 may be used in methods of dispersing cells in a culture medium seeded into a well of a cell culture container or in methods of coating a well of a cell culture container with a coating material (e.g., extracellular matrix).
The following method relies on: a device according to the invention is provided and a cell culture vessel containing one or more colonies of a cell culture is placed on the device. In certain embodiments, it will be desirable to secure the cell culture container to the stage. For example, the cell culture vessel may be fixed to the stage by fitting the cell culture vessel and the guide.
In some embodiments, the cell culture may have been incubated in the presence of a separation fluid that may be subsequently removed, inactivated or neutralized. When the one or more colonies of cultured cells are adhered directly or indirectly to a bottom of a well of the cell culture vessel, it may be desirable to use a separation fluid. Common examples of separation fluids include ReLeSRTM(Stem cell technology Co.) and STEMdiffTMNeural Rosette selection reagent (stem cell technologies). See general separation liquids, in particular, ReLeSRTMAnd STEMdiffTMThe neural Rosette selection reagent, such a separation fluid may be added to a suitable cell culture and retained for a short period of time (e.g., 1 to 15 minutes) and then removed, before incubating the cell culture for a further period of time. After such incubation, some or all of the colonies may have been or are susceptible to being peeled from the well bottom with minimal force.
In other embodiments, the cell culture may have been incubated in the presence of a dissociation solution that may be subsequently removed, inactivated or neutralized. When used with cells that grow as a monolayer, it may be desirable to use a dissociation solution. A common example of a dissociation solution is trypsin. One skilled in the art will appreciate that for certain cell lines or cell types, overexposure to a dissociation solution may completely dissociate one or more colonies in a cell culture and/or may disrupt the cell culture.
In other embodiments, the cell culture may be placed on the device while the cell culture is incubated (in the presence of the stripping or dissociation solution). In such embodiments, one or more colonies in the cell culture may be dissociated simultaneously by use of the device of the invention, or immediately after a sufficient incubation period by use of the device of the invention. In some embodiments, certain stripping or dissociation solutions may work best at a given temperature (i.e., 37 ℃ or higher). In some embodiments, it may be desirable to provide the device of the present invention with a heating element for heating the platform and/or a housing surrounding the device or the platform.
Regardless of how the aforementioned stripping or dissociation is actually performed, after the cell culture has been incubated for a sufficient time, the one or more colonies in the cell culture may have been conveniently dissociated into smaller units using a device as described herein. Rotating the platform under the influence of the drive, as described above, brings one or more impact brackets into contact with one or more impact bumpers, thereby transferring a dissociation force to the one or more colonies in the cell culture.
In some embodiments, it may be desirable to adjust the rotational speed of the driver, and thus the rotational speed of the platform, in order to optimally dissociate the one or more colonies in the cell culture. By adjusting the upward rotational speed of the driver, the impact frequency can be increased. Likewise, adjusting the downward rotational speed of the driver reduces the impact frequency. One skilled in the art will recognize that the appropriate frequency of impact may depend on the particular cell line or cell type being cultured.
In some embodiments, it may be desirable to adjust the rotational direction of the driver to optimally dissociate the one or more colonies in the cell culture. In one embodiment, the stage is rotated in a clockwise direction. In another embodiment, the stage is rotated in a counter-clockwise direction. In yet another embodiment, the stage is rotated in a clockwise or counterclockwise direction.
In yet another embodiment, rotating the stage may include regularly alternating between a clockwise direction and a counterclockwise direction. In embodiments that include regularly alternating the direction of rotation of the stage in a clockwise direction and a counter-clockwise direction, the regular alternating may include a delay of less than five seconds between rotating in the clockwise direction and the counter-clockwise direction. In a more specific embodiment, the method includes regularly changing the direction of rotation of the stage between clockwise and counterclockwise, and the regularly changing may include a delay of less than 1 second between clockwise and counterclockwise rotation. In more specific embodiments, the method includes regularly reversing the direction of rotation of the stage in a clockwise direction and a counterclockwise direction, which may include a delay of about 0.5 milliseconds or less between rotation in the clockwise direction and the counterclockwise direction.
In embodiments that include adjusting the rotational speed, direction, or acceleration of the drive, such operations may be performed by a controller as described above. Accordingly, certain embodiments of the method of the present disclosure may further include using a controller to control the rotational speed, direction, or acceleration of the driver.
Some embodiments of the methods disclosed herein particularly relate to dissociating one or more undifferentiated colonies of pluripotent stem cells (such as, but not limited to, human pluripotent stem cells). In such a process, it is preferred to utilize certain separation fluids (such as, but not limited to, ReLeSR)TM) It may be desirable to selectively exfoliate undifferentiated colonies of pluripotent stem cells. Accordingly, a selective separation liquid (such as, but not limited to, ReLeSR)TM) Methods matching the use of the device of the invention advantageously allow selection of a desired cell type while maintaining a single cell cultureThe one or more colonies that are present that are desired dissociate into smaller units.
In embodiments where one or more undifferentiated colonies of human pluripotent stem cells in a cell culture are dissociated, an isolation solution (such as, but not limited to, ReLeSR)TM) Adhesion of undifferentiated colonies of human pluripotent stem cells to the bottom of the wells of the cell culture vessel can be attenuated. Upon addition of a volume of solution (such as, but not limited to, cell culture medium) to the cells, some or all of one or more colonies of human pluripotent stem cells may be detached from the bottom of the well and suspended in the solution. Upon rotation of the platform by the actuator and repeated collisions of one or more impact brackets with one or more impact bumpers, any remaining undifferentiated colonies of human pluripotent stem cells attached to the bottom of the well can become detached from the bottom of the well. Concurrently with the selection of one or more undifferentiated colonies of human pluripotent stem cells, these colonies are divided into smaller units (i.e., clumps) when the colonies collide with each other and with the walls of the wells of the cell culture vessel.
In an alternative embodiment, for example, but not limited to, during one differentiation experiment, it may be desirable to select one or more differentiation colonies of pluripotent stem cells. Following the same procedure as described above, the detached and dissociated pluripotent stem cells may be aspirated from the wells of the cell culture container and discarded to generate the (differentiated) target colonies attached to the bottoms of the wells for further culture or processing.
While the present invention has been described in connection with various embodiments for illustrative purposes, the technical teachings of the applicant are not intended to be limited to such embodiments, as the described embodiments of the present invention are intended to be exemplary. On the contrary, the applicant's technical teachings described and illustrated herein encompass various alternatives, modifications and equivalents without departing from the described embodiments of the present invention and the general scope thereof as defined by the appended claims.

Claims (73)

1.一种自动化系统,用于自适应地传代细胞培养容器内的细胞培养基中的细胞培养物,所述自动化系统包括:1. An automated system for adaptively passage of a cell culture in a cell culture medium in a cell culture vessel, the automated system comprising: 一个成像模块,用于在一个第一时间点以及一个或多个后续时间点采集所述细胞培养物的一张或多张图像;an imaging module for acquiring one or more images of the cell culture at a first time point and at one or more subsequent time points; 一个移液器模块,具有一个或多个移液器,用于通过与所述一个或多个移液器的端部配合的一个移液器吸头从所述细胞培养容器中吸取液体;a pipette module having one or more pipettes for aspirating liquid from the cell culture vessel through a pipette tip mated with the ends of the one or more pipettes; 一个液体分配器模块,与所述移液器模块间隔开,且所述液体分配器模块与一个以上储液器呈流体连通;a liquid dispenser module spaced apart from the pipette module, and the liquid dispenser module is in fluid communication with more than one reservoir; 一个处理模块,具有一对相对的臂,用于在所述自动化系统内夹持和运送所述细胞培养容器或其盖子或是一个子代细胞培养容器或其盖子;以及a processing module having a pair of opposed arms for holding and transporting the cell culture vessel or its lid or a daughter cell culture vessel or its lid within the automated system; and 至少一个处理器,其与所述成像模块、所述移液器模块、所述液体分配器模块以及所述处理模块相连通,所述处理器被配置为:At least one processor in communication with the imaging module, the pipette module, the liquid dispenser module, and the processing module, the processor configured to: 接收来自于所述成像模块的所述一张或多张图像;receiving the one or more images from the imaging module; 基于从所述成像模块接收到的所述一张或多张图像,计算所述细胞培养物的一个或多个特征;以及computing one or more features of the cell culture based on the one or more images received from the imaging module; and 执行一个自动传代实验计划,以传代所述细胞培养物,所述实验计划包括协调所述移液器模块、所述液体分配器模块以及所述成像模块的操作,所述协调基于将所述细胞培养物的计算出的所述一个或多个特征与Performing an automated passaging experimental plan to passage the cell culture, the experimental plan including coordinating the operations of the pipette module, the liquid dispenser module, and the imaging module based on the cells The calculated one or more characteristics of the culture are related to a)所述一个或多个特征的一个已知阈值水平;或a) a known threshold level of the one or more characteristics; or b)所述一个或多个特征的一个输入阈值水平;b) an input threshold level for the one or more features; 进行的比较。comparison made. 2.根据权利要求1的所述自动化系统,其特征在于:所述一个或多个特征包括:2. The automated system of claim 1, wherein the one or more features comprise: a)所述细胞培养物的融合度的度量;a) a measure of the degree of confluency of the cell culture; b)所述细胞培养物的细胞或集落的形态的度量;b) a measure of the morphology of the cells or colonies of the cell culture; c)所述细胞培养物的细胞或集落的分化的度量;c) a measure of differentiation of cells or colonies of said cell culture; d)所述细胞培养物的集落大小分布的度量;d) a measure of the colony size distribution of the cell culture; e)a)、b)、c)或d)从所述第一时间点到所述一个或多个后续时间点的变化的度量;或e) a measure of the change in a), b), c) or d) from said first time point to said one or more subsequent time points; or f)a)相对于b)、c)或d)的度量,b)相对于a)、c)或d)的度量,c)相对于a)、b)或d)的度量,或d)相对于a)、b)或c)的度量。f) a) a measure relative to b), c) or d), b) a measure relative to a), c) or d), c) a measure relative to a), b) or d), or d) Measure relative to a), b) or c). 3.根据权利要求2的所述自动化系统,其特征在于:所述已知或输入阈值水平为:3. The described automation system according to claim 2, wherein: the known or input threshold level is: i、对于a),细胞或集落融合度大约在30-90%之间;i. For a), the degree of cell or colony confluency is approximately between 30-90%; ii、对于b),大约在一种对照培养物的±30%之间;ii. For b), approximately between ± 30% of a control culture; iii、对于c),大约在一个维持实验计划中的一种对照培养物的0-30%之间,或者大约在一个分化实验计划中的一种对照培养物的50%-100%之间;或iii. For c), approximately between 0-30% of a control culture in a maintenance protocol, or approximately between 50%-100% of a control culture in a differentiation protocol; or iv、对于d),大约在一种对照培养物的一个平均集落大小分布15%或其子分数以内。iv. For d), within approximately 15% or a sub-fraction of a mean colony size distribution of a control culture. 4.根据权利要求1-3中任意一项的所述自动化系统,其特征在于:在所述第一时间点或所述一个或多个后续时间点,计算出的关于所述细胞培养容器中的所述细胞培养物的所述一个或多个特征,与一个第二细胞培养容器中的所述第二细胞培养物是不同的,并且所述一个或多个特征在一个随后传代过程中变得更加一致。4. The automated system according to any one of claims 1-3, characterized in that: at the first time point or the one or more subsequent time points, the calculated information about the cell culture vessel The one or more characteristics of the cell culture are different from the second cell culture in a second cell culture vessel and the one or more characteristics change during a subsequent passage be more consistent. 5.根据权利要求1-4中任意一项的所述自动化系统,其特征在于:所述成像模块包括一台照相机,能够分辨所述培养容器中的单个细胞。5. The automated system according to any one of claims 1-4, wherein the imaging module comprises a camera capable of distinguishing individual cells in the culture vessel. 6.根据权利要求1-5中任意一项的所述自动化系统,其特征在于:所述自动化系统还包括一个载物台模块,用于支撑所述细胞培养容器。6. The automated system according to any one of claims 1-5, wherein the automated system further comprises a stage module for supporting the cell culture vessel. 7.根据权利要求6的所述自动化系统,其特征在于:所述载物台模块在一个第一平面内沿一条第一轴线或一条第二轴线或沿二者是可移动的。7. The automated system of claim 6, wherein the stage module is movable in a first plane along a first axis or a second axis or both. 8.根据权利要求6或7的所述自动化系统,其特征在于:所述载物台模块或其子部件绕其边缘沿一条第三轴线枢转。8. The automation system of claim 6 or 7, wherein the stage module or sub-components thereof pivot about its edge along a third axis. 9.根据权利要求1-8中任意一项的所述自动化系统,其特征在于:所述一个或多个移液器被附接到一个滑架上。9. The automated system of any of claims 1-8, wherein the one or more pipettes are attached to a carriage. 10.根据权利要求1-9中任意一项的所述自动化系统,其特征在于:所述液体分配器模块包括一根以上的导管,且每根导管与所述一个以上储液器中的单独一个呈流体连通。10. The automated system of any one of claims 1-9, wherein the liquid distributor module comprises more than one conduit, and each conduit is separate from the one or more reservoirs One is in fluid communication. 11.根据权利要求10的所述自动化系统,其特征在于:所述液体分配器模块包括一根第一导管,其与一种第一溶液的一个储液器呈流体连通;以及一根第二导管,其与一种第二溶液的一个储液器呈流体连通;并且所述第一溶液和所述第二溶液同时被分配到一个子代细胞培养容器中。11. The automated system of claim 10, wherein the liquid dispenser module includes a first conduit in fluid communication with a reservoir of a first solution; and a second conduit a conduit in fluid communication with a reservoir of a second solution; and the first solution and the second solution are simultaneously dispensed into a daughter cell culture vessel. 12.根据权利要求10或11的所述自动化系统,其特征在于:每根导管是可重复使用或可更换的。12. The automated system of claim 10 or 11, wherein each conduit is reusable or replaceable. 13.根据权利要求1-12中任意一项的所述自动化系统,其特征在于:还包括一个壳体,所述壳体至少要容纳所述像模块、移液器模块、液体分配器模块、载物台模块和处理模块。13. The automation system according to any one of claims 1-12, characterized in that: it further comprises a housing, and the housing is to accommodate at least the image module, the pipette module, the liquid dispenser module, Stage Module and Handling Module. 14.根据权利要求13的所述自动化系统,其特征在于:所述壳体是无菌的。14. The automated system of claim 13, wherein the housing is sterile. 15.根据权利要求13或14的所述自动化系统,其特征在于:还包括一个制冷模块,用于存放所述一个以上储液器中的一个或多个以及一个储水器,其中,所述一个以上储液器、所述制冷模块以及所述废料储存器位于所述壳体的外部。15. The automation system according to claim 13 or 14, characterized in that it further comprises a refrigeration module for storing one or more of the one or more accumulators and a water accumulator, wherein the One or more accumulators, the refrigeration module, and the waste storage are located outside the housing. 16.根据权利要求15的所述自动化系统,其特征在于:所述废料储存器与所述壳体内的一个废料槽呈流体连通。16. The automated system of claim 15, wherein the waste reservoir is in fluid communication with a waste tank within the housing. 17.根据权利要求16的所述自动化系统,其特征在于:所述废料槽涂覆有一疏水涂层。17. The automated system of claim 16, wherein the waste chute is coated with a hydrophobic coating. 18.根据权利要求15-17中任意一项的所述自动化系统,其特征在于:还包括一个或多个传感器,其中所述一个或多个传感器被配置为检测并报告所述成像模块上、所述载物台模块上或在所述一个以上储液器中的负载质量,以便于18. The automated system of any one of claims 15-17, further comprising one or more sensors, wherein the one or more sensors are configured to detect and report on the imaging module, the load mass on the stage module or in the one or more reservoirs to facilitate a)检测所述成像模块上、所述载物台模块上或所述一个以上储液器中的负载质量;以及a) detecting a load mass on the imaging module, on the stage module, or in the one or more reservoirs; and b)在所述负载质量不同于预期时触发一个警报。b) Trigger an alarm when the load quality is different than expected. 19.根据权利要求13-18中任意一项的所述自动化系统,其特征在于:还包括一个封闭传送机模块,其连接至所述壳体和一个培养箱模块,并用于将所述细胞培养容器从所述培养箱模块传送到所述处理模块的附近。19. The automated system according to any one of claims 13-18, further comprising a closed conveyor module connected to the housing and an incubator module for culturing the cells Containers are transferred from the incubator module to the vicinity of the processing module. 20.根据权利要求19的所述自动化系统,其特征在于:所述培养箱模块维持用于所述细胞培养物的允许环境条件。20. The automated system of claim 19, wherein the incubator module maintains permissible environmental conditions for the cell culture. 21.根据权利要求1-20中任意一项的所述自动化系统,其特征在于:还包括一个图形用户界面。21. The automation system of any one of claims 1-20, further comprising a graphical user interface. 22.根据权利要求21的所述自动化系统,其特征在于:所述图形用户界面就所述一个以上储液器中的每一个显示一个液位报告。22. The automated system of claim 21, wherein the graphical user interface displays a level report for each of the one or more reservoirs. 23.一种自动化系统,用于自适应传代细胞培养容器内的细胞培养基中的多能干细胞粘附培养物,所述自动化系统包括:23. An automated system for an adherent culture of pluripotent stem cells in a cell culture medium in an adaptive passage cell culture vessel, the automated system comprising: 一个成像模块,用于在一个第一时间点以及一个或多个后续时间点采集所述多能干细胞培养物的一张或多张图像;an imaging module for acquiring one or more images of the pluripotent stem cell culture at a first time point and at one or more subsequent time points; 一个移液器模块,其具有一个或多个移液器,以用于通过与所述一个或多个移液器的端部相配合的一个移液器吸头从所述细胞培养容器中吸取液体;A pipette module having one or more pipettes for aspirating from the cell culture vessel by a pipette tip mated with the end of the one or more pipettes liquid; 一个液体分配器模块,其与所述移液器模块间隔开,且所述液体分配器模块与一个以上储液器呈流体连通;a liquid dispenser module spaced from the pipette module, and the liquid dispenser module is in fluid communication with more than one reservoir; 一个处理模块,其具有一对相对的臂,用于在所述自动化系统内夹持和运送所述细胞培养容器或其盖子或是一个子代细胞培养容器或其盖子的;以及a processing module having a pair of opposed arms for holding and transporting the cell culture vessel or its lid or a daughter cell culture vessel or its lid within the automated system; and 至少一个处理器,其与所述成像模块、所述移液器模块、所述液体分配器模块以及处理模块相连通,所述处理器被配置为:At least one processor in communication with the imaging module, the pipette module, the liquid dispenser module, and the processing module, the processor configured to: 接收来自于所述成像模块的一张或多张图像;receiving one or more images from the imaging module; 基于从所述成像模块接收到的所述一张或多张图像,计算所述多能干细胞培养物的一个或多个特征;以及computing one or more characteristics of the pluripotent stem cell culture based on the one or more images received from the imaging module; and 执行一个自动传代实验计划,以传代所述多能干细胞培养物,所述实验计划包括所述移液器模块、所述液体分配器模块以及所述成像模块的操作协调,所述操作协调基于将所述多能干细胞培养物的计算出的所述一个或多个特征与Execute an automated passaging experimental plan to passage the pluripotent stem cell culture, the experimental plan including the coordination of operations of the pipette module, the liquid dispenser module, and the imaging module based on the The calculated one or more characteristics of the pluripotent stem cell culture are related to a)所述一个或多个特征的一个已知阈值水平;或a) a known threshold level of the one or more characteristics; or b)所述一个或多个特征的一个输入阈值水平;b) an input threshold level for the one or more features; 进行比较。Compare. 24.根据权利要求23的所述自动化系统,其特征在于:所述一个或多个特征包括:24. The automated system of claim 23, wherein the one or more characteristics comprise: a)所述细胞培养物的融合度的度量;a) a measure of the degree of confluency of the cell culture; b)所述细胞培养物的细胞或集落的形态的度量;b) a measure of the morphology of the cells or colonies of the cell culture; c)所述细胞培养物的细胞或集落的分化的度量;c) a measure of differentiation of cells or colonies of said cell culture; d)所述细胞培养物的集落大小分布的度量;d) a measure of the colony size distribution of the cell culture; e)a)、b)、c)或d)从所述第一时间点到所述一个或多个后续时间点的变化的度量;或e) a measure of the change in a), b), c) or d) from said first time point to said one or more subsequent time points; or f)a)相对于b)、c)或d)的度量,b)相对于a)、c)或d)的度量,c)相对于a)、b)或d)的度量,或d)相对于a)、b)或c)的度量。f) a) a measure relative to b), c) or d), b) a measure relative to a), c) or d), c) a measure relative to a), b) or d), or d) Measure relative to a), b) or c). 25.根据权利要求24的所述自动化系统,其特征在于:所述已知或输入阈值水平为:25. The automated system of claim 24, wherein the known or input threshold level is: i、对于a),细胞或集落融合度大约在30-90%之间;i. For a), the degree of cell or colony confluency is approximately between 30-90%; ii、对于b),大约在一种对照培养物的±30%之间;ii. For b), approximately between ± 30% of a control culture; iii、对于c),大约在一个维持实验计划中的一种对照培养物的0-30%之间,或者大约在一个分化实验计划中的一种对照培养物的50%-100%之间;或iii. For c), approximately between 0-30% of a control culture in a maintenance protocol, or approximately between 50%-100% of a control culture in a differentiation protocol; or iv、对于d),大约在一种对照培养物的一个平均集落大小的15%以内或其子分数以内。iv. For d), within approximately 15% or a subfraction of a mean colony size of a control culture. 26.根据权利要求23-25中任意一项的所述自动化系统,其特征在于:在所述第一时间点或一个或多个后续时间点,计算出的关于与所述细胞培养容器中的所述多能干细胞培养物所述一个或多个特征,与一个第二细胞培养容器中的所述第二多能干细胞培养物是不同的,并且所述一个或多个特征在一个随后传代过程中变得更加一致。26. The automated system according to any one of claims 23-25, characterized in that: at the first time point or one or more subsequent time points, the calculated relation to the cell culture vessel in the The one or more characteristics of the pluripotent stem cell culture are different from the second pluripotent stem cell culture in a second cell culture vessel, and the one or more characteristics are in a subsequent passaging process become more consistent. 27.根据权利要求23-26中任意一项的所述自动化系统,其特征在于:所述成像模块包括一台照相机,能够分辨所述培养容器中的单个细胞。27. The automated system of any one of claims 23-26, wherein the imaging module includes a camera capable of resolving individual cells in the culture vessel. 28.根据权利要求23-27中任意一项的所述自动化系统,其特征在于:所述自动化系统还包括一个载物台模块,用于支撑细胞培养容器。28. The automated system of any one of claims 23-27, wherein the automated system further comprises a stage module for supporting the cell culture vessel. 29.根据权利要求28的所述自动化系统,其特征在于:所述载物台模块在一个第一平面内沿一条第一轴线或一条第二轴线或沿二者是可以移动的。29. The automated system of claim 28, wherein the stage module is movable in a first plane along a first axis or a second axis or both. 30.根据权利要求28或29的所述自动化系统,其特征在于:所述载物台模块或其子部件绕其边缘沿一条第三轴线枢转。30. The automated system of claim 28 or 29, wherein the stage module or sub-component thereof pivots about its edge along a third axis. 31.根据权利要求23-30中任意一项的所述自动化系统,其特征在于:所述一个或多个移液器附接到一个滑架上。31. The automated system of any of claims 23-30, wherein the one or more pipettes are attached to a carriage. 32.根据权利要求23-31中任意一项的所述自动化系统,其特征在于:所述液体分配器模块包括一根以上的导管,且每根导管与一个以上储液器中的单独一个呈流体连通。32. The automated system of any one of claims 23-31, wherein the liquid dispenser module comprises more than one conduit, and each conduit is in the form of a single one of the more than one reservoirs. fluid communication. 33.根据权利要求32的所述自动化系统,其特征在于:所述液体分配器模块包括一根第一导管,该导管与一种第一溶液的一个储存器呈流体连通;以及一根第二导管,该导管与一种第二溶液的一个储存器呈流体连通;并且所述第一溶液和所述第二溶液同时被分配到一个子代细胞培养容器中。33. The automated system of claim 32, wherein the liquid dispenser module comprises a first conduit in fluid communication with a reservoir of a first solution; and a second conduit a conduit in fluid communication with a reservoir of a second solution; and the first solution and the second solution are simultaneously dispensed into a daughter cell culture vessel. 34.根据权利要求32或33的所述自动化系统,其特征在于:每根导管是可重复使用或可更换的。34. The automated system of claim 32 or 33, wherein each conduit is reusable or replaceable. 35.根据权利要求23-34中任意一项的所述自动化系统,其特征在于:还包括一个壳体,用于至少容纳所述成像模块、移液器模块、液体分配器模块、载物台模块和处理模块。35. The automated system according to any one of claims 23-34, further comprising a housing for containing at least the imaging module, the pipette module, the liquid dispenser module, and the stage modules and processing modules. 36.根据权利要求35的所述自动化系统,其特征在于:所述壳体是无菌的。36. The automated system of claim 35, wherein the housing is sterile. 37.根据权利要求35或36的所述自动化系统,其特征在于:还包括一个制冷模块,以用于存放所述一个以上储液器中的一个或多个以及一个储水器,其中所述一个以上储液器、所述制冷模块以及所述废料储存器位于所述壳体的外部。37. The automation system of claim 35 or 36, further comprising a refrigeration module for storing one or more of the one or more accumulators and a water accumulator, wherein the One or more accumulators, the refrigeration module, and the waste storage are located outside the housing. 38.根据权利要求37的所述自动化系统,其特征在于:所述废料储存器与所述壳体内的一个废料槽呈流体连通。38. The automated system of claim 37, wherein the waste reservoir is in fluid communication with a waste tank within the housing. 39.根据权利要求38的所述自动化系统,其特征在于:所述废料槽涂覆有一疏水涂层。39. The automated system of claim 38, wherein the waste chute is coated with a hydrophobic coating. 40.根据权利要求37-39中任意一项的所述自动化系统,其特征在于:还包括一个或多个传感器,其中所述一个或多个传感器被配置为检测并报告在所述成像模块上、所述载物台模块上或在所述一个以上储液器中的负载质量,以便于40. The automated system of any one of claims 37-39, further comprising one or more sensors, wherein the one or more sensors are configured to detect and report on the imaging module , the load mass on the stage module or in the one or more reservoirs to facilitate a)检测所述成像模块、所述载物台模块或所述一个以上储液器中的负载质量;以及a) detecting a load mass in the imaging module, the stage module, or the one or more reservoirs; and b)在所述负载质量不同于预期时触发一个警报。b) Trigger an alarm when the load quality is different than expected. 41.根据权利要求35-40中任意一项的所述自动化系统,其特征在于:还包括一个封闭传送机模块,其连接至所述壳体和一个培养箱模块,并用于将所述细胞培养容器从所述培养箱模块传送到所述处理模块的附近。41. The automated system of any one of claims 35-40, further comprising a closed conveyor module connected to the housing and an incubator module for culturing the cells Containers are transferred from the incubator module to the vicinity of the processing module. 42.根据权利要求41的所述自动化系统,其特征在于:所述培养箱模块维持用于所述多能干细胞培养物的允许环境条件。42. The automated system of claim 41, wherein the incubator module maintains permissive environmental conditions for the pluripotent stem cell culture. 43.根据权利要求23-42中任意一项的所述自动化系统,其特征在于:还包括一个图形用户界面。43. The automation system of any of claims 23-42, further comprising a graphical user interface. 44.根据权利要求43的所述自动化系统,其特征在于:所述图形用户界面就所述一个以上储液器中的每一个显示一个液位报告。44. The automated system of claim 43, wherein the graphical user interface displays a level report for each of the one or more reservoirs. 45.用于自适应传代细胞培养物的一种自动化方法,其包括:45. An automated method for adaptive passage of cell cultures, comprising: 在一个细胞培养容器内的一个细胞培养基中提供所述细胞培养物;providing the cell culture in a cell culture medium within a cell culture vessel; 通过一个成像模块在一个第一时间点和随后的一个或多个时间点采集所述细胞培养物的一张或多张图像;acquiring, by an imaging module, one or more images of the cell culture at a first time point and at one or more subsequent time points; 基于所述一张或多张图像,通过与所述成像模块通信耦合的至少一个处理器来计算所述细胞培养物的一个或多个特征;以及computing, by at least one processor communicatively coupled with the imaging module, one or more characteristics of the cell culture based on the one or more images; and 通过所述至少一个处理器来执行一个自动传代实验计划,该执行基于将计算出的所述细胞培养物的所述一个或多个特征与Executing, by the at least one processor, an automated passaging experimental plan based on comparing the calculated one or more characteristics of the cell culture with a)所述一个或多个特征的一个已知阈值水平;或者a) a known threshold level of the one or more characteristics; or b)所述一个或多个特征的一个预设阈值水平;b) a preset threshold level of the one or more features; 进行比较。Compare. 46.根据权利要求45的所述自动化系统,其特征在于:所述一个或多个特征包括:46. The automated system of claim 45, wherein the one or more characteristics comprise: a)所述细胞培养物的融合度的度量;a) a measure of the degree of confluency of the cell culture; b)所述细胞培养物的细胞或集落的形态的度量;b) a measure of the morphology of the cells or colonies of the cell culture; c)所述细胞培养物的细胞或集落的分化的度量;c) a measure of differentiation of cells or colonies of said cell culture; d)所述细胞培养物的集落大小分布的度量;d) a measure of the colony size distribution of the cell culture; e)a)、b)、c)或d)从所述第一时间点到所述一个或多个后续时间点的变化的度量;或e) a measure of the change in a), b), c) or d) from said first time point to said one or more subsequent time points; or f)a)相对于b)、c)或d)的度量,b)相对于a)、c)或d)的度量,c)相对于a)、b)或d)的度量,或d)相对于a)、b)或c)的度量。f) a) a measure relative to b), c) or d), b) a measure relative to a), c) or d), c) a measure relative to a), b) or d), or d) Measure relative to a), b) or c). 47.根据权利要求46的所述自动化系统,其特征在于:所述已知或输入阈值水平为:47. The automated system of claim 46, wherein the known or input threshold level is: i、对于a),细胞或集落融合度大约在30-90%之间;i. For a), the degree of cell or colony confluency is approximately between 30-90%; ii、对于b),大约在一种对照培养物的±30%之间;ii. For b), approximately between ± 30% of a control culture; iii、对于c),大约在一个维持实验计划中的一种对照培养物的0-30%之间,或者大约在一个分化实验计划中的一种对照培养物的50%-100%之间;或iii. For c), approximately between 0-30% of a control culture in a maintenance protocol, or approximately between 50%-100% of a control culture in a differentiation protocol; or iv、对于d),就而言,大约在一种对照培养物的一个平均集落大小分布的15%以内或其子分数以内。iv. For d), for that matter, within approximately 15% of a mean colony size distribution of a control culture, or a sub-fraction thereof. 48.根据权利要求45-47中任意一项的所述自动化系统,其特征在于:在所述第一时间点或一个或多个后续时间点,计算出的关于与所述细胞培养容器中的所述细胞培养物的所述一个或多个特征,与一个第二细胞培养容器中的所述第二细胞培养物是不同的,并且所述一个或多个特征在一个随后传代过程中变得更加一致。48. The automated system according to any one of claims 45-47, characterized in that: at the first time point or one or more subsequent time points, the calculated correlation with the cell culture vessel in the The one or more characteristics of the cell culture are different from the second cell culture in a second cell culture vessel and the one or more characteristics become different during a subsequent passage more consistent. 49.根据权利要求45-48中任意一项的所述自动化方法,其特征在于:提供所述细胞培养物包括将所述细胞培养物从所述培养箱转移。49. The automated method of any one of claims 45-48, wherein providing the cell culture comprises transferring the cell culture from the incubator. 50.根据权利要求45-49中任意一项的所述自动化方法,其特征在于:还包括将所述细胞培养容器放置在一个载物台模块上。50. The automated method of any one of claims 45-49, further comprising placing the cell culture vessel on a stage module. 51.根据权利要求45-50中任意一项的所述自动化方法,其特征在于:还包括从所述细胞培养物中获得一细胞悬液,并将所述细胞悬液的部分或全部接种到一个子代细胞培养容器中。51. The automated method according to any one of claims 45-50, further comprising obtaining a cell suspension from the cell culture, and inoculating part or all of the cell suspension into in a daughter cell culture vessel. 52.根据权利要求51的所述自动化方法,其特征在于:接种到所述子代细胞培养容器中之前,将所述细胞悬液通过一个第一移液器吸头传递,从而将所述细胞培养物解离成一单细胞悬液或多个簇,所述簇平均直径不超过所述第一移液器吸头的孔直径。52. The automated method of claim 51, wherein the cell suspension is passed through a first pipette tip prior to inoculation into the progeny cell culture vessel, whereby the cells are The culture dissociates into a single cell suspension or clusters with an average diameter that does not exceed the hole diameter of the first pipette tip. 53.根据权利按要求51或52的所述自动化方法,其特征在于:所述细胞悬液的获得包括从所述细胞培养容器中吸出所述细胞培养基,并使所述细胞培养容器中的所述细胞培养物与一种分离液接触。53. The automated method according to claim 51 or 52, wherein the obtaining of the cell suspension comprises aspirating the cell culture medium from the cell culture vessel and allowing the cell culture vessel to The cell culture is contacted with a separation fluid. 54.根据权利要求53的所述自动化方法,其特征在于:所述分离液是一种解离溶液,并且所述解离溶液选择性地从所述细胞培养容器的壁上剥离出第一组分化细胞或第二组未分化细胞。54. The automated method of claim 53, wherein the separation solution is a dissociation solution, and the dissociation solution selectively strips the first group from the wall of the cell culture vessel Differentiated cells or a second set of undifferentiated cells. 55.根据权利要求51-54中任意一项的所述自动化方法,其特征在于:还包括在接种所述细胞悬液之前,将一种第一溶液和一种第二溶液同时分配到所述子代细胞培养容器中。55. The automated method of any one of claims 51-54, further comprising simultaneously distributing a first solution and a second solution to the cell prior to inoculating the cell suspension daughter cell culture vessel. 56.根据权利要求55的所述自动化方法,其特征在于:所述第一溶液是所述细胞培养基,所述第二溶液是一种溶解的细胞外基质。56. The automated method of claim 55, wherein the first solution is the cell culture medium and the second solution is a solubilized extracellular matrix. 57.根据权利要求45-56中任意一项的所述自动化方法,其特征在于:所述细胞培养物是多能干细胞。57. The automated method of any one of claims 45-56, wherein the cell culture is pluripotent stem cells. 58.根据权利要求57的所述自动化方法,其特征在于:所述多能干细胞是人类的多能干细胞。58. The automated method of claim 57, wherein the pluripotent stem cells are human pluripotent stem cells. 59.根据权利要求57或58的所述自动化方法,其特征在于:所述多能干细胞以簇传代。59. The automated method of claim 57 or 58, wherein the pluripotent stem cells are passaged in clusters. 60.一种用于适应性地传代一种多能粘附细胞培养物的自动化方法,其包括:60. An automated method for adaptively passaging a pluripotent adherent cell culture, comprising: 在一个细胞培养容器内的一个细胞培养基中提供所述细胞培养物;providing the cell culture in a cell culture medium within a cell culture vessel; 通过一个成像模块在一个第一时间点和随后的一个或多个时间点采集所述细胞培养物的一张或多张图像;acquiring, by an imaging module, one or more images of the cell culture at a first time point and at one or more subsequent time points; 基于所述一张或多张图像,通过与所述成像模块通信耦合的至少一个处理器来计算所述多能干细胞培养物的一个或多个特征;以及computing, by at least one processor communicatively coupled with the imaging module, one or more characteristics of the pluripotent stem cell culture based on the one or more images; and 通过所述至少一个处理器执行一个自动传代实验计划,该执行基于将计算出的所述多能干细胞培养物的所述一个或多个特与Executing, by the at least one processor, an automated passaging experimental plan based on applying the calculated one or more characteristics of the pluripotent stem cell culture a)所述一个或多个特征的一个已知阈值水平;或是a) a known threshold level of the one or more characteristics; or b)所述一个或多个特征的一个输入阈值水平;b) an input threshold level for the one or more features; 进行比较。Compare. 61.根据权利要求60的所述自动化系统,其特征在于:所述一个或多个特征包括:61. The automated system of claim 60, wherein the one or more characteristics comprise: a)所述多能干细胞培养物的融合度的度量;a) a measure of the degree of confluency of the pluripotent stem cell culture; b)所述多能干细胞培养物的细胞或集落的形态的度量;b) a measure of the morphology of the cells or colonies of the pluripotent stem cell culture; c)所述多能干细胞培养的细胞或集落的分化的度量;c) a measure of differentiation of cells or colonies of the pluripotent stem cell culture; d)所述多能干细胞培养物的集落大小分布的度量;d) a measure of the colony size distribution of the pluripotent stem cell culture; e)a)、b)、c)或d)从所述第一时间点到所述一个或多个后续时间点的变化的度量;或e) a measure of the change in a), b), c) or d) from said first point in time to said one or more subsequent points in time; or f)a)相对于b)、c)或d)的度量,b)相对于a)、c)或d)的度量,c)相对于a)、b)或d)的度量,或d)相对于a)、b)或c)的度量。f) a) a measure relative to b), c) or d), b) a measure relative to a), c) or d), c) a measure relative to a), b) or d), or d) Measure relative to a), b) or c). 62.根据权利要求61的所述自动化系统,其特征在于:所述已知或输入阈值水平为:62. The automated system of claim 61, wherein the known or input threshold level is: i、对于a),细胞或集落融合度大约在30-90%之间;i. For a), the degree of cell or colony confluency is approximately between 30-90%; ii、对于b),大约在一种对照培养物的±30%之间;ii. For b), approximately between ± 30% of a control culture; iii、对于c),维持实验计划中的对照培养物的约0-30%,或分化实验计划中的对照培养物的约50%-100%;或iii. For c), maintain about 0-30% of the control culture in the experimental plan, or differentiate about 50%-100% of the control culture in the experimental plan; or iv、对于d),大约在一种对照培养物的一个平均集落大小分布的15%以内或其子分数以内。iv. For d), within approximately 15% or a sub-fraction of a mean colony size distribution of a control culture. 63.根据权利要求60-62中任意一项的所述自动化系统,其特征在于:在所述第一时间点或一个或多个后续时间点,计算出的关于与所述细胞培养容器中的所述多能干细胞培养物的所述一个或多个特征,与一个第二细胞培养容器中的所述第二多能干细胞培养物是不同的,并且在一个随后传代过程中,所述一个或多个特征变得更加一致。63. The automated system according to any one of claims 60-62, characterized in that: at the first time point or one or more subsequent time points, the calculated correlation with the cell culture vessel in the The one or more characteristics of the pluripotent stem cell culture are different from the second pluripotent stem cell culture in a second cell culture vessel, and during a subsequent passage, the one or Several features became more consistent. 64.根据权利要求60-63中任意一项的所述自动化方法,其特征在于:所述多能干(粘附的)细胞培养物的提供,包括将所述细胞培养物从所述培养箱中转移。64. The automated method of any one of claims 60-63, wherein the providing of the pluripotent stem (adherent) cell culture comprises removing the cell culture from the incubator transfer. 65.根据权利要求60-64中任意一项的所述自动化方法,其特征在于:还包括将所述细胞培养容器放置在一个载物台模块上。65. The automated method of any one of claims 60-64, further comprising placing the cell culture vessel on a stage module. 66.根据权利要求65的所述自动化方法,其特征在于:还包括从所述细胞培养容器中吸出所述细胞培养基,并使所述细胞培养容器中的所述多能干粘附的细胞培养物与一种分离液接触以产生一细胞悬液。66. The automated method of claim 65, further comprising aspirating the cell culture medium from the cell culture vessel and making the pluripotent stem adherent cell culture in the cell culture vessel The substance is contacted with a separation solution to produce a cell suspension. 67.根据权利要求66的所述自动化方法,其特征在于:所述分离液是一种解离溶液,其产生所述细胞悬液,所述细胞悬液作为从所述细胞培养容器壁上选择性剥离的第一组分化细胞或第二组未分化细胞。67. The automated method of claim 66, wherein the separation solution is a dissociation solution that produces the cell suspension as selected from the cell culture vessel wall Sexually stripped first group of differentiated cells or second group of undifferentiated cells. 68.根据权利要求66或67的所述自动化方法,其特征在于:所述细胞悬液包括多能干细胞簇,所述簇平均直径不超过能使所述细胞悬液通过的一个第一移液器吸头的孔径。68. The automated method of claim 66 or 67, wherein the cell suspension comprises clusters of pluripotent stem cells, the clusters having an average diameter no greater than a first pipetting through which the cell suspension can pass The hole diameter of the pipette tip. 69.根据权利要求66-68中任意一项的所述自动化方法,其特征在于:还包括将所述细胞悬液接种到一个子代培养容器中。69. The automated method of any one of claims 66-68, further comprising inoculating the cell suspension into a progeny culture vessel. 70.根据权利要求69的所述自动化方法,其特征在于:还包括在接种所述细胞悬液之前将一种第一溶液和一种第二溶液同时分配到所述子代培养容器中。70. The automated method of claim 69, further comprising simultaneously dispensing a first solution and a second solution into the progeny culture vessel prior to seeding the cell suspension. 71.根据权利要求70的所述自动化方法,其特征在于:所述第一溶液是所述细胞培养基,所述第二溶液是一种溶解的细胞外基质。71. The automated method of claim 70, wherein the first solution is the cell culture medium and the second solution is a solubilized extracellular matrix. 72.根据权利要求60-71中任意一项的所述自动化方法,其特征在在于:所述多能干细胞是人类的。72. The automated method of any one of claims 60-71, wherein the pluripotent stem cells are human. 73.一种系统、装置或方法,其包括如上所述的和/或如上所请求保护的和/或如附图中所示的特征的一个或多个的组合。73. A system, apparatus or method comprising a combination of one or more of the features as described above and/or as claimed above and/or as shown in the accompanying drawings.
CN201980054961.1A 2018-06-19 2019-06-19 System, method and device for automatic cell culture Pending CN112585257A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862686962P 2018-06-19 2018-06-19
US62/686,962 2018-06-19
PCT/CA2019/050859 WO2019241885A1 (en) 2018-06-19 2019-06-19 Systems, methods and apparatus for the automated culture of cells

Publications (1)

Publication Number Publication Date
CN112585257A true CN112585257A (en) 2021-03-30

Family

ID=68982573

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201980054961.1A Pending CN112585257A (en) 2018-06-19 2019-06-19 System, method and device for automatic cell culture
CN201980097636.3A Pending CN114008189A (en) 2018-06-19 2019-12-18 Adaptive passaging systems, methods and devices for cell cultures

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201980097636.3A Pending CN114008189A (en) 2018-06-19 2019-12-18 Adaptive passaging systems, methods and devices for cell cultures

Country Status (6)

Country Link
US (3) US20210317399A1 (en)
EP (2) EP3810749A4 (en)
JP (3) JP7396564B2 (en)
KR (2) KR102813362B1 (en)
CN (2) CN112585257A (en)
WO (2) WO2019241885A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019046304A1 (en) 2017-08-28 2019-03-07 Matthias Wagner Microfluidic laser-activated intracellular delivery systems and methods
WO2019241885A1 (en) * 2018-06-19 2019-12-26 Stemcell Technologies Canada Inc. Systems, methods and apparatus for the automated culture of cells
US10775395B2 (en) * 2018-10-18 2020-09-15 Arctoris Limited System and method of performing a biological experiment with adaptive cybernetic control of procedural conditions
WO2020097083A1 (en) 2018-11-06 2020-05-14 Cellino Biotech, Inc. Systems for cell control
ES2973723T3 (en) * 2018-11-30 2024-06-24 Amgen Inc Systems and procedures to detect the cytopathic effect in cells
US20220282203A1 (en) 2021-03-07 2022-09-08 Cellino Biotech, Inc. Platforms and systems for automated cell culture
WO2022194730A1 (en) * 2021-03-19 2022-09-22 Aixinno Limited System for cultivating biological cell cultures
CN113699042B (en) * 2021-08-17 2022-07-22 华艾博越(上海)生物医疗科技有限公司 Control system of cell culture box
US11931737B2 (en) 2021-09-02 2024-03-19 Cellino Biotech, Inc. Platforms and systems for automated cell culture
CN119137259A (en) * 2022-04-27 2024-12-13 日商乐华股份有限公司 Subculture timing determination method, subculture timing determination system, and cell culture system
TW202432821A (en) * 2023-01-16 2024-08-16 日商阪神化成工業股份有限公司 Equipment for cell culture and cell culture method
WO2024158817A1 (en) * 2023-01-25 2024-08-02 Beckman Coulter, Inc. Normalization of seeding of bioreactors
WO2024181548A1 (en) * 2023-03-02 2024-09-06 オムロン株式会社 Seeding device, seeding method, and program
JP7665103B1 (en) * 2023-11-09 2025-04-18 三菱電機株式会社 Microalgae culture support device, microalgae culture system using the same, and microalgae culture support method
US12116562B1 (en) * 2023-12-16 2024-10-15 Unicorn Biotechnologies Ltd. Integrated system for the automated passaging of anchorage dependent cell cultures
CN119359643B (en) * 2024-09-30 2025-06-10 广州光影细胞科技有限公司 Cell growth remote real-time analysis monitoring system

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1598415A1 (en) * 2004-05-20 2005-11-23 The Automation Partnership (Cambridge) Limited Smart cell culture
CA2607217A1 (en) * 2005-05-06 2006-11-16 Fraunhofer-Gesellschaft Zur Foerderund Der Angewandten Forschung E.V. Method of cultivating a cell culture is an automated cell culture system as well as an automated cell culture system
US20110124037A1 (en) * 2006-09-22 2011-05-26 Aviso Gmbh Method and Device for Automated Removal of Cells and/or Cell Colonies
WO2015023658A2 (en) * 2013-08-12 2015-02-19 Invivosciences Inc. Automated cell culture system and method
WO2017221155A1 (en) * 2016-06-20 2017-12-28 Genesis Technologies Limited Automated cell processing systems and methods
CN107922904A (en) * 2015-03-31 2018-04-17 兴盛生物科技股份有限公司 For being produced from the cell retainer of somatic therapy
CN107949835A (en) * 2015-03-31 2018-04-20 兴盛生物科技股份有限公司 Device is grown in cell culture training with integrated imaging system

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101443445B (en) * 2006-03-17 2012-07-04 塞拉提斯股份公司 Culture system and method for propagation of human blastocyst-derived stem cells
US9365821B2 (en) * 2009-09-01 2016-06-14 Mcmaster University Transformed human pluripotent stem cells and associated methods
JP5740101B2 (en) * 2010-04-23 2015-06-24 国立大学法人名古屋大学 Cell evaluation apparatus, incubator, cell evaluation method, cell evaluation program, and cell culture method
JP5691009B2 (en) * 2010-07-28 2015-04-01 パナソニックヘルスケアホールディングス株式会社 Imaging device
JP2012231764A (en) * 2011-05-08 2012-11-29 Kyokko Denki Kk Apparatus and method for sorting and acquiring cell aggregate
WO2012170995A2 (en) * 2011-06-10 2012-12-13 University Of Georgia Research Foundation, Inc. Avian induced pluripotent stem cells and their use
JP5849498B2 (en) * 2011-07-29 2016-01-27 株式会社ニコン Culture state evaluation apparatus, cell culture method and program
US10428309B2 (en) * 2011-12-01 2019-10-01 New York Stem Cell Foundation, Inc. Systems and methods for producing stem cells and differentiated cells
US20150017711A1 (en) * 2012-02-02 2015-01-15 Corning Incorporated Cell culture systems
EP2708890B1 (en) * 2012-09-14 2015-11-18 Molecular Devices (New Milton) Ltd Method of selecting a monoclonal cell colony
JP6762080B2 (en) * 2014-06-30 2020-09-30 澁谷工業株式会社 Automatic culture operation device
US10138456B2 (en) * 2014-07-22 2018-11-27 Hitachi High-Technologies Corporation Cell concentration adjustment device, and automatic subculture system using same
WO2016161169A2 (en) * 2015-03-31 2016-10-06 Thrive Bioscience, Inc. Cell culture incubators with integrated cell manipulation systems
CN105112360A (en) * 2015-07-17 2015-12-02 深圳爱生再生医学科技有限公司 Mass culture method of umbilical cord mesenchymal stem cells
CN108138130A (en) * 2015-08-31 2018-06-08 爱平世股份有限公司 The method of multipotential stem cell manufacture system and production induced multi-potent stem cell
US10184104B2 (en) * 2015-11-19 2019-01-22 Alexander Lee Lianides Automated system for cultivating transgenic C. elegans
EP3566051A4 (en) * 2017-01-06 2020-11-04 Mantra Bio, Inc. Systems and methods for algorithmic extracellular vesicle population discovery and characterization
DE202017101988U1 (en) * 2017-04-04 2017-08-09 Tecan Trading Ag Automated system for the cultivation and differentiation of pluripotent stem cells
US11149245B2 (en) * 2017-04-04 2021-10-19 Tecan Trading Ag Automated system for maintenance and differentiation of pluripotent stem cells
JP6823541B2 (en) * 2017-05-30 2021-02-03 株式会社荏原製作所 Calibration method and calibration program
JP2019050798A (en) * 2017-07-05 2019-04-04 株式会社Screenホールディングス Sample container
JP7018955B2 (en) * 2017-10-03 2022-02-14 オリンパス株式会社 Culture information processing equipment
WO2019241885A1 (en) * 2018-06-19 2019-12-26 Stemcell Technologies Canada Inc. Systems, methods and apparatus for the automated culture of cells

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1598415A1 (en) * 2004-05-20 2005-11-23 The Automation Partnership (Cambridge) Limited Smart cell culture
US20050260743A1 (en) * 2004-05-20 2005-11-24 Drake Rosemary A L Smart cell culture
CA2607217A1 (en) * 2005-05-06 2006-11-16 Fraunhofer-Gesellschaft Zur Foerderund Der Angewandten Forschung E.V. Method of cultivating a cell culture is an automated cell culture system as well as an automated cell culture system
US20110124037A1 (en) * 2006-09-22 2011-05-26 Aviso Gmbh Method and Device for Automated Removal of Cells and/or Cell Colonies
WO2015023658A2 (en) * 2013-08-12 2015-02-19 Invivosciences Inc. Automated cell culture system and method
CN107922904A (en) * 2015-03-31 2018-04-17 兴盛生物科技股份有限公司 For being produced from the cell retainer of somatic therapy
CN107949835A (en) * 2015-03-31 2018-04-20 兴盛生物科技股份有限公司 Device is grown in cell culture training with integrated imaging system
WO2017221155A1 (en) * 2016-06-20 2017-12-28 Genesis Technologies Limited Automated cell processing systems and methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
谭逸斌;张宇翔;李中源;张启英;顾宁;: "一种可实现原位监测的细胞培养信息化装置", 科学通报, vol. 59, no. 11, pages 1026 - 1032 *

Also Published As

Publication number Publication date
EP3987001A1 (en) 2022-04-27
US20220315877A1 (en) 2022-10-06
CN114008189A (en) 2022-02-01
WO2020252560A1 (en) 2020-12-24
JP2024133239A (en) 2024-10-01
US20210317399A1 (en) 2021-10-14
US20250163359A1 (en) 2025-05-22
KR20210024039A (en) 2021-03-04
KR102813362B1 (en) 2025-05-27
WO2019241885A1 (en) 2019-12-26
JP2021527440A (en) 2021-10-14
EP3810749A1 (en) 2021-04-28
EP3810749A4 (en) 2022-04-20
JP2022537441A (en) 2022-08-25
EP3987001A4 (en) 2023-08-02
JP7396564B2 (en) 2023-12-12
KR20220024475A (en) 2022-03-03
US12258552B2 (en) 2025-03-25

Similar Documents

Publication Publication Date Title
CN112585257A (en) System, method and device for automatic cell culture
US11796552B2 (en) Automated cell processing systems and methods
US11149245B2 (en) Automated system for maintenance and differentiation of pluripotent stem cells
Conway et al. Scalable 96-well plate based iPSC culture and production using a robotic liquid handling system
JPWO2020252560A5 (en)
DE202017101988U1 (en) Automated system for the cultivation and differentiation of pluripotent stem cells
CN117070360A (en) Organoid culture method and production system
JPWO2019241885A5 (en)
Ochs et al. Needle to needle robot‐assisted manufacture of cell therapy products
EP2574658A1 (en) Arrangement for handling a plurality of containers
Sandell et al. Mammalian cell culture
Warner et al. Mammalian cell culture
AU2017202224B2 (en) Automated system for maintenance and differentiation of pluripotent stem cells
Zhu et al. Advancing regenerative medicine: the Aceman system’s pioneering automation and machine learning in mesenchymal stem cell biofabrication
AU2017100376A4 (en) Automated system for maintenance and differentiation of pluripotent stem cells
Wang et al. Towards the Upscaling of Mesenchymal Stromal Cells Biomanufacturing Enhanced by the Automated Cell Manufacturing Platform
CN108300648B (en) Cell culture bottle place support
Weiß et al. Routine Challenges and Solutions in Cell Biology

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination